FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Masaaki Inaba

Research Profile

Procedures

Renal Dialysis

Disorders

Chemicals & Drugs

Concepts & Ideas

Anatomy

Physiology

Bone Resorption

Co-author Network

Publications

TOP 3
Eiji Ishimura; Yoshiki Nishizawa; Kyoko Norimine; Senji Okuno; Shigeichi Shoji; Naoki Tsuboniwa; Kenjiro Yamakawa; Tomoyuki Yamakawa; Shinya Fukumoto; Masaaki Inaba
Significant positive association between parathyroid hormone and fat mass and lean mass in chronic hemodialysis patients.
Katsuhito Mori; Senji Okuno; Shigeichi Shoji; Tetsuo Shoji; Kenjiro Yamakawa; Tomoyuki Yamakawa; Masanori Emoto; Yasuo Imanishi; Eiji Ishimura; Yoshinori Kakutani; Masaaki Inaba
Tumor necrosis factor-related apoptosis-inducing ligand as an independent predictor of mortality in hemodialysis patents.
Yuko Yamazaki; Masanori Emoto; Shinya Fukumoto; Naoya Kawano; Eiko Lee; Katsuhito Mori; Tomoaki Morioka; Koka Motoyama; Yoshiki Nishizawa; Tetsuo Shoji; Shoko Tsuchikura; Hiromi Urata; Masaaki Inaba
Clinical impact of the leptin to soluble leptin receptor ratio on subclinical carotid atherosclerosis in patients with type 2 diabetes.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Masaaki Inaba (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Eiji Ishimura; Yoshiki Nishizawa; Kyoko Norimine; Senji Okuno; Shigeichi Shoji; Naoki Tsuboniwa; Kenjiro Yamakawa; Tomoyuki Yamakawa; Shinya Fukumoto; Masaaki Inaba
Significant positive association between parathyroid hormone and fat mass and lean mass in chronic hemodialysis patients.
The Journal of clinical endocrinology and metabolism 2013;98(3):1264-70.
2013: Katsuhito Mori; Senji Okuno; Shigeichi Shoji; Tetsuo Shoji; Kenjiro Yamakawa; Tomoyuki Yamakawa; Masanori Emoto; Yasuo Imanishi; Eiji Ishimura; Yoshinori Kakutani; Masaaki Inaba
Tumor necrosis factor-related apoptosis-inducing ligand as an independent predictor of mortality in hemodialysis patents.
Cytokine 2013;61(3):912-6.
2013: Yuko Yamazaki; Masanori Emoto; Shinya Fukumoto; Naoya Kawano; Eiko Lee; Katsuhito Mori; Tomoaki Morioka; Koka Motoyama; Yoshiki Nishizawa; Tetsuo Shoji; Shoko Tsuchikura; Hiromi Urata; Masaaki Inaba
Clinical impact of the leptin to soluble leptin receptor ratio on subclinical carotid atherosclerosis in patients with type 2 diabetes.
Journal of atherosclerosis and thrombosis 2013;20(2):186-94.
2013: Senji Okuno; S Shoji; N Tsuboniwa; K Yamakawa; Tomoyuki Yamakawa; Eiji Ishimura; K Mori; Yoshiki Nishizawa; K Norimine; Masaaki Inaba
Significant inverse relationship between serum undercarboxylated osteocalcin and glycemic control in maintenance hemodialysis patients.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2013;24(2):605-12.
2013: Yosuke Wakita; Shinsuke Yamada; Koichiro Yoda; Masanori Emoto; Yasuo Imanishi; Eiji Ishimura; Toshiki Nagasaki; Yuki Nagata; Masaaki Inaba
Thyroid heterogeneity, as indicated by the CV of ultrasonographic intensities, correlates with anti-thyroid peroxidase antibodies in euthyroid Hashimoto's thyroiditis.
Thyroid research 2013;6(1):5.
2013: Yoshiki Nishizawa; Hiroaki Ohta; Masataka Shiraki; Junichi Takada; Osamu Chaki; Saeko Fujiwara; Masao Fukunaga; Hiroshi Hagino; Schoichi Ichimura; Masaaki Inaba; Takami Miki; Masakazu Miura; Noriko Yoshimura
Guidelines for the use of bone metabolic markers in the diagnosis and treatment of osteoporosis (2012 edition).
Journal of bone and mineral metabolism 2013;31(1):1-15.
2012: Koichiro Yoda; Maki Yoda; Takashi Mishima; Katsuhito Mori; Shinsuke Yamada; Masanori Emoto; Mitsuru Ichii; Yasuo Imanishi; Masaaki Inaba
Impaired response of FGF-23 to oral phosphate in patients with type 2 diabetes: a possible mechanism of atherosclerosis.
The Journal of clinical endocrinology and metabolism 2012;97(11):E2036-43.
2012: Shinsuke Yamada; Masaaki Inaba
[Diabetes mellitus and osteoporosis. Bone metabolic disorder in diabetic nephropathy].
Clinical calcium 2012;22(9):1333-41.
2012: Shinsuke Yamada; Masaaki Inaba
[Diabetes and sleeping habits].
Nihon rinsho. Japanese journal of clinical medicine 2012;70(7):1200-5.
2012: Shinya Fukumoto; Masaaki Inaba; Eiji Ishimura; Eiji Kimoto; Hidenori Koyama; Tomoaki Morioka; Koka Motoyama; Yoshiki Nishizawa; Shigeichi Shoji; Tetsuo Shoji; Ken Wakikawa; Masanori Emoto
Antialbuminuric advantage of cilnidipine compared with L-type calcium channel blockers in type 2 diabetic patients with normoalbuminuria and microalbuminuria.
Diabetes research and clinical practice 2012;97(1):91-8.
2012: Tetsuo Shoji; Tatsuji Takahashi; Masanori Emoto; Shinya Fukumoto; Akihide Matsumoto; Katsuhito Mori; Tomoaki Morioka; Yoshiki Nishizawa; Masaaki Inaba
Thrice-weekly insulin injection with nurse's support for diabetic hemodialysis patients having difficulty with self injection.
Osaka city medical journal 2012;58(1):35-8.
2012: Masaaki Inaba
[Significance of marker for bone metabolism].
Clinical calcium 2012;22(6):839-44.
2012: Maki Yoda; Yasuo Imanishi; Masaaki Inaba; Eiji Ishimura; Katsuhito Mori; Senji Okuno; Tetsuo Shoji; Shinsuke Yamada; Tomoyuki Yamakawa; Koichiro Yoda; Shigeichi Shoji
Poor muscle quality as a predictor of high mortality independent of diabetes in hemodialysis patients.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2012;66(4):266-70.
2012: Katsuhito Mori; Tomoaki Morioka; Koka Motoyama; Tetsuo Shoji; Shinsuke Yamada; Masanori Emoto; Yasuo Imanishi; Eiko Lee; Masaaki Inaba
Undercarboxylated osteocalcin does not correlate with insulin resistance as assessed by euglycemic hyperinsulinemic clamp technique in patients with type 2 diabetes mellitus.
Diabetology & metabolic syndrome 2012;4(1):53.
2012: Yoshiteru Ohno; Wakaba Fukushima; Masaaki Inaba; Eiji Ishimura; Kyoko Kondo; Kayo Mui; Toshihide Naganuma; Yoshio Hirota
Prevalence of and factors associated with chronic kidney disease (CKD) in Japanese subjects without notable chronic diseases, undergoing an annual health checkup.
Kidney & blood pressure research 2012;36(1):139-48.
2012: Yasuo Imanishi; Yuki Nagata; Masaaki Inaba
Parathyroid diseases and animal models.
Frontiers in endocrinology 2012;3():78.
2012: Yohei Mima; Yoshiki Nishizawa; Masahiro Okada; Tetsuo Shoji; Shinji Tanaka; Masanori Emoto; Shinya Fukumoto; Tsutomu Furuzono; Hidenori Koyama; Masaaki Inaba
Enhancement of cell-based therapeutic angiogenesis using a novel type of injectable scaffolds of hydroxyapatite-polymer nanocomposite microspheres.
PloS one 2012;7(4):e35199.
2012: Katsuhito Mori; Masanori Emoto; Masaaki Inaba
Fetuin-A and the cardiovascular system.
Advances in clinical chemistry 2012;56():175-95.
2012: Masaaki Inaba; Kiyoshi Kurokawa; Akira Saito; Tetsuo Shoji; Takashi Akiba; Tadao Akizawa; Yasuaki Hayashino; Shunichi Fukuhara
Disappearance of association in diabetic patients on hemodialysis between anemia and mortality risk: the Japan dialysis outcomes and practice pattern study.
Nephron. Clinical practice 2012;120(2):c91-c100.
2012: Naoya Kawano; Hidenori Koyama; Katsuhito Mori; Tomoaki Morioka; Koka Motoyama; Yoshiki Nishizawa; Yasuhisa Okuno; Tetsuo Shoji; Shoko Tsuchikura; Hiromi Urata; Yuko Yamazaki; Masanori Emoto; Shinya Fukumoto; Masaaki Inaba
Association of endothelial and vascular smooth muscle dysfunction with cardiovascular risk factors, vascular complications, and subclinical carotid atherosclerosis in type 2 diabetic patients.
Journal of atherosclerosis and thrombosis 2012;19(3):276-84.
2012: Yasuo Imanishi; Wataru Ando; Jun Hashimoto; Hiroshi Kaji; Keisuke Kobayashi; Yasato Komatsu; Hajime M Koyano; Takami Miki; Akimitsu Miyauchi; Katsuhito Mori; Tomoaki Morioka; Yuki Nagata; Koichi Oba; Takatoshi Saito; Takafumi Ueda; Masaaki Inaba
Matrix extracellular phosphoglycoprotein is expressed in causative tumors of oncogenic osteomalacia.
Journal of bone and mineral metabolism 2012;30(1):93-9.
2011: Akinobu Ochi; Tetsuo Shoji; Tsutomu Tabata; Yoshihiro Tsujimoto; Hiroshi Yasuda; Eiji Ishimura; Ryusuke Kakiya; Katsuhito Mori; Yoshiki Nishizawa; Masaaki Inaba
Trace elements in the hair of hemodialysis patients.
Biological trace element research 2011;143(2):825-34.
2011: Eiji Ishimura; Yoshiki Nishizawa; Senji Okuno; S Shoji; N Tsuboniwa; K Yamakawa; Tomoyuki Yamakawa; M Ichii; Masaaki Inaba
Effect of cinacalcet on bone mineral density of the radius in hemodialysis patients with secondary hyperparathyroidism.
Clinical nephrology 2011;76(4):259-65.
2011: Yuki Nagata; Hiroshi Naka; Masanori Emoto; Yasuo Imanishi; Akira Ishii; Masafumi Kurajoh; Takami Miki; Katsuhito Mori; Tomoaki Morioka; Koka Motoyama; Masaaki Inaba
Evaluation of bone markers in hypophosphatemic rickets/osteomalacia.
Endocrine 2011;40(2):315-7.
2011: Mizuki Aimoto; Mika Akahori-Nakamae; Mitsuru Ichii; Masaaki Inaba; Eiji Ishimura; Hideo Koh; Ki-Ryang Koh; Katsuhito Mori; Ran Moriguchi-Aimoto; Hirohisa Nakamae; Takahiko Nakane; Takafumi Nakao; Saori Nishiki-Kosaka; Masahiko Ohsawa; Yasunobu Takeoka; Yoshiki Terada; Eri Wada-Inoue; Kenichi Wakasa; Takahisa Yamane; Masayuki Hino
[Membranous nephropathy with nephrotic syndrome developed after allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia].
[Rinshō ketsueki] The Japanese journal of clinical hematology 2011;52(7):556-62.
2011: Yasuo Imanishi; Andrew Arnold; Takehisa Kawata; Takao Kenko; Takami Miki; Nobuo Nagano; Michihito Wada; Masaaki Inaba
Cinacalcet HCl suppresses Cyclin D1 oncogene-derived parathyroid cell proliferation in a murine model for primary hyperparathyroidism.
Calcified tissue international 2011;89(1):29-35.
2011: Yoshihiro Tsujimoto; Masanori Emoto; Eiji Ishimura; Hidenori Koyama; Yoshiki Nishizawa; Tetsuo Shoji; Tsutomu Tabata; Hideki Tahara; Masaaki Inaba
Active vitamin D and acute respiratory infections in dialysis patients.
Clinical journal of the American Society of Nephrology : CJASN 2011;6(6):1361-7.
2011: Katsuhito Mori; Masanori Emoto; Masaaki Inaba
Fetuin-A: a multifunctional protein.
Recent patents on endocrine, metabolic & immune drug discovery 2011;5(2):124-46.
2011: Akihiro Tamori; Tatsuya Koike; Hitoshi Goto; Shigeyuki Wakitani; Masahiro Tada; Hiroyasu Morikawa; Masaru Enomoto; Masaaki Inaba; Tatsuya Nakatani; Masayuki Hino; Norifumi Kawada
Prospective study of reactivation of hepatitis B virus in patients with rheumatoid arthritis who received immunosuppressive therapy: evaluation of both HBsAg-positive and HBsAg-negative cohorts.
Journal of gastroenterology 2011;46(4):556-64.
2011: Hiroki Ueno; Hidenori Koyama; Shinya Fukumoto; Shinji Tanaka; Tetsuo Shoji; Tetsuo Shoji; Masanori Emoto; Hideki Tahara; Masaaki Inaba; Ryusuke Kakiya; Tsutomu Tabata; Toshio Miyata; Yoshiki Nishizawa
Advanced glycation end products, carotid atherosclerosis, and circulating endothelial progenitor cells in patients with end-stage renal disease.
Metabolism: clinical and experimental 2011;60(4):453-9.
2011: Naoya Kawano; Katsuhito Mori; Masanori Emoto; Eiko Lee; Ikue Kobayashi; Yuko Yamazaki; Hiromi Urata; Tomoaki Morioka; Hidenori Koyama; Tetsuo Shoji; Yoshiki Nishizawa; Masaaki Inaba
Association of serum TRAIL levels with atherosclerosis in patients with type 2 diabetes mellitus.
Diabetes research and clinical practice 2011;91(3):316-20.
2011: M Kurajoh; Masaaki Inaba; Senji Okuno; H Nagayama; Shinsuke Yamada; Yasuo Imanishi; Eiji Ishimura; S Shoji; Tomoyuki Yamakawa; Yoshiki Nishizawa
Reduction of whole PTH/intact PTH ratio as a predictor of bone metabolism in cinacalcet treatment of hemodialysis patients with secondary hyperparathyroidism.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2011;22(3):923-30.
2011: Shinya Nakatani; Min Wei; Shotaro Yamano; Masaaki Inaba; Eiji Ishimura; Anna Kakehashi; Katsuhito Mori; Hideki Wanibuchi
Targeted proteomics of isolated glomeruli from the kidneys of diabetic rats: sorbin and SH3 domain containing 2 is a novel protein associated with diabetic nephropathy.
Experimental diabetes research 2011;2011():979354.
2011: Eiji Ishimura; Yoshiki Nishizawa; Senji Okuno; Shigeichi Shoji; Naoki Tsuboniwa; Tomoyuki Yamakawa; Masaaki Inaba
Relationship between fat mass and serum high-sensitivity C-reactive protein levels in prevalent hemodialysis patients.
Nephron. Clinical practice 2011;119(4):c283-8.
2011: Hiroki Ueno; Masanori Emoto; Shinya Fukumoto; Hidenori Koyama; Yohei Mima; Yoshiki Nishizawa; Takuhito Shoji; Tetsuo Shoji; Shinji Tanaka; Masaaki Inaba
Comparison of the effect of cilostazol with aspirin on circulating endothelial progenitor cells and small-dense LDL cholesterol in diabetic patients with cerebral ischemia: a randomized controlled pilot trial.
Journal of atherosclerosis and thrombosis 2011;18(10):883-90.
2010: Keiji Okamoto; Masaaki Inaba; Yutaka Furumitsu; Akihiko Ban; Naoto Mori; Kazuhiko Yukioka; Yasuo Imanishi; Yoshiki Nishizawa
Beneficial effect of risedronate on arterial thickening and stiffening with a reciprocal relationship to its effect on bone mass in female osteoporosis patients: a longitudinal study.
Life sciences 2010;87(23-26):686-91.
2010: Yohei Mima; Shinya Fukumoto; Hiroki Ueno; Hidenori Koyama; Shinji Tanaka; Tomoaki Morioka; Koka Motoyama; Masanori Emoto; Tetsuo Shoji; Yoshiki Nishizawa; Masaaki Inaba
Different effects of diabetic autonomic neuropathy on regional transcutaneous oxygen tension in patients with peripheral arterial disease.
Osaka city medical journal 2010;56(2):27-36.
2010: Masaaki Inaba; M Kurajoh; Senji Okuno; Yasuo Imanishi; Shinsuke Yamada; Katsuhito Mori; Eiji Ishimura; Tomoyuki Yamakawa; Yoshiki Nishizawa
Poor muscle quality rather than reduced lean body mass is responsible for the lower serum creatinine level in hemodialysis patients with diabetes mellitus.
Clinical nephrology 2010;74(4):266-72.
2010: Hiroki Ueno; Shinya Fukumoto; Hidenori Koyama; Shinji Tanaka; Takaaki Maeno; Masahiro Murayama; Yoshiko Otsuka; Yohei Mima; Yuji Kawaguchi; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Regions of arterial stenosis and clinical factors determining transcutaneous oxygen tension in patients with peripheral arterial disease.
Journal of atherosclerosis and thrombosis 2010;17(8):858-69.
2010: Hiroki Ueno; Hidenori Koyama; Takuhito Shoji; Masayo Monden; Shinya Fukumoto; Shinji Tanaka; Yoshiko Otsuka; Yohei Mima; Tomoaki Morioka; Katsuhito Mori; Atsushi Shioi; Hiroshi Yamamoto; Masaaki Inaba; Yoshiki Nishizawa
Receptor for advanced glycation end-products (RAGE) regulation of adiposity and adiponectin is associated with atherogenesis in apoE-deficient mouse.
Atherosclerosis 2010;211(2):431-6.
2010: Hideaki Shima; Masaaki Inaba
[Calcitonin (CT), procalcitonin (PCT)].
Nihon rinsho. Japanese journal of clinical medicine 2010;68 Suppl 7():325-7.
2010: Akira Ishii; Yasuo Imanishi; Keisuke Kobayashi; Jun Hashimoto; Takafumi Ueda; Akimitsu Miyauchi; Hajime M Koyano; Hiroshi Kaji; Takatoshi Saito; Koichi Oba; Yasato Komatsu; Masafumi Kurajoh; Yuki Nagata; Hitoshi Goto; Kenichi Wakasa; Toshitsugu Sugimoto; Takami Miki; Masaaki Inaba; Yoshiki Nishizawa
The levels of somatostatin receptors in causative tumors of oncogenic osteomalacia are insufficient for their agonist to normalize serum phosphate levels.
Calcified tissue international 2010;86(6):455-62.
2010: Masanori Emoto; Katsuhito Mori; Eiko Lee; Naoya Kawano; Yuko Yamazaki; Shoko Tsuchikura; Tomoaki Morioka; Hidenori Koyama; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Fetuin-A and atherosclerotic calcified plaque in patients with type 2 diabetes mellitus.
Metabolism: clinical and experimental 2010;59(6):873-8.
2010: Hideaki Shima; Eiji Ishimura; Toshihide Naganuma; Takeshi Yamazaki; Ikue Kobayashi; Kaori Shidara; Katsuhito Mori; Yoshiaki Takemoto; Tetsuo Shoji; Masaaki Inaba; Mikio Okamura; Tatsuya Nakatani; Yoshiki Nishizawa
Cerebral microbleeds in predialysis patients with chronic kidney disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2010;25(5):1554-9.
2010: Tetsuo Shoji; Kiyoshi Maekawa; Masanori Emoto; Senji Okuno; Tomoyuki Yamakawa; Eiji Ishimura; Masaaki Inaba; Yoshiki Nishizawa
Arterial stiffness predicts cardiovascular death independent of arterial thickness in a cohort of hemodialysis patients.
Atherosclerosis 2010;210(1):145-9.
2010: Hidenori Koyama; Sanae Fukuda; Tetsuo Shoji; Masaaki Inaba; Yoshihiro Tsujimoto; Tsutomu Tabata; Senji Okuno; Tomoyuki Yamakawa; Shigeki Okada; Mikio Okamura; Hirohiko Kuratsune; Hisako Fujii; Yoshinobu Hirayama; Yasuyoshi Watanabe; Yoshiki Nishizawa
Fatigue is a predictor for cardiovascular outcomes in patients undergoing hemodialysis.
Clinical journal of the American Society of Nephrology : CJASN 2010;5(4):659-66.
2010: Katsuhito Mori; Yuji Ikari; Shuichi Jono; Atsushi Shioi; Eiji Ishimura; Masanori Emoto; Masaaki Inaba; Kazuhiro Hara; Yoshiki Nishizawa
Association of serum TRAIL level with coronary artery disease.
Thrombosis research 2010;125(4):322-5.
2010: Shinsuke Yamada; Masaaki Inaba; Shigeki Okada; Yasuo Imanishi; Katsuhito Mori; Masanori Emoto; Eiji Ishimura; Yoshiki Nishizawa
Association of glycated albumin, but not glycated hemoglobin, with calcaneus quantitative ultrasound in male hemodialysis patients with type 2 diabetes mellitus.
Metabolism: clinical and experimental 2010;59(3):390-4.
2010: Toshiki Nagasaki; Masaaki Inaba; Misako Fujiwara-Ueda; Junko Nishio; Yasuro Kumeda; Yoshikazu Hiura; Hideki Tahara; Eiji Ishimura; Osamu Ishiko; Yoshiki Nishizawa
Thyroid blood flow as a useful predictor of relapse of Graves' disease after normal delivery in patients with Graves' disease.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2010;64(2):113-7.
2010: Akihiko Ban; Masaaki Inaba; Yutaka Furumitsu; Keiji Okamoto; Kazuhiko Yukioka; Hitoshi Goto; Yoshiki Nishizawa
Time-course of health status in patients with rheumatoid arthritis during the first year of treatment with infliximab.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2010;64(2):107-12.
2010: Shigeru Sugiguchi; Hitoshi Goto; Masaaki Inaba; Yoshiki Nishizawa
Preferential reduction of bone mineral density at the femur reflects impairment of physical activity in patients with low-activity rheumatoid arthritis.
Modern rheumatology / the Japan Rheumatism Association 2010;20(1):69-73.
2010: Katsuhito Mori; Shuichi Jono; Masanori Emoto; Takahiko Kawagishi; Hideo Yasumoto; Toshiaki Konishi; Yutaka Furumitsu; Atsushi Shioi; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Effects of pravastatin on serum osteoprotegerin levels in patients with hypercholesterolemia and type 2 diabetes.
Angiology 2010;61(1):86-91.
2010: Akira Ishii; Yasuo Imanishi; Masafumi Kurajoh; Yuki Nagata; Keisuke Kobayashi; Takami Miki; Masaaki Inaba; Yoshiki Nishizawa
The administration of an active vitamin D(3) analogue reduced the serum concentrations of 1-84 and truncated parathyroid hormone in pseudohypoparathyroidism type Ib patients.
Endocrine journal 2010;57(7):609-14.
2010: Shoko Tsuchikura; Tetsuo Shoji; Naoko Shimomura; Ryusuke Kakiya; Masanori Emoto; Hidenori Koyama; Eiji Ishimura; Masaaki Inaba; Yoshiki Nishizawa
Serum C-reactive protein and thioredoxin levels in subjects with mildly reduced glomerular filtration rate.
BMC nephrology 2010;11():7.
2010: Mitsuru Ichii; Eiji Ishimura; Senji Okuno; Hidenori Chou; Yoko Kato; Naoki Tsuboniwa; Kyoko Nagasue; Kiyoshi Maekawa; Tomoyuki Yamakawa; Masaaki Inaba; Yoshiki Nishizawa
Decreases in parathyroid gland volume after cinacalcet treatment in hemodialysis patients with secondary hyperparathyroidism.
Nephron. Clinical practice 2010;115(3):c195-202.
2009: Yasuo Imanishi; Masaaki Inaba; Takehisa Kawata; Yoshiki Nishizawa
Cinacalcet in hyperfunctioning parathyroid diseases.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2009;13 Suppl 1():S7-S11.
2009: Yoshifumi Maeno; Masaaki Inaba; Senji Okuno; Kaori Kohno; Kiyoshi Maekawa; Tomoyuki Yamakawa; Eiji Ishimura; Yoshiki Nishizawa
Significant association of fracture of the lumbar spine with mortality in female hemodialysis patients: a prospective observational study.
Calcified tissue international 2009;85(4):310-6.
2009: Yasuo Imanishi; Masaaki Inaba; Takehisa Kawata; Yoshiki Nishizawa
Animal models of hyperfunctioning parathyroid diseases for drug development.
Expert opinion on drug discovery 2009;4(7):727-40.
2009: Kaori Shidara; Masaaki Inaba
[Bone metabolic marker for osteoporosis].
Nihon rinsho. Japanese journal of clinical medicine 2009;67(5):927-31.
2009: Masaaki Inaba
[Chronic kidney disease (CKD) and bone. Impact of diabetes mellitus on the development of CKD-MBD].
Clinical calcium 2009;19(4):502-7.
2009: Eiko Lee; Masanori Emoto; Megumi Teramura; Shoko Tsuchikura; Hiroki Ueno; Kayo Shinohara; Tomoaki Morioka; Katsuhito Mori; Hidenori Koyama; Tetsuo Shoji; Yasuhisa Okuno; Masaaki Inaba; Yoshiki Nishizawa
The combination of IMT and stiffness parameter beta is highly associated with concurrent coronary artery disease in type 2 diabetes.
Journal of atherosclerosis and thrombosis 2009;16(1):33-9.
2009: Kaori Kohno; Masaaki Inaba; Senji Okuno; Yoshifumi Maeno; Kiyoshi Maekawa; Tomoyuki Yamakawa; Eiji Ishimura; Yoshiki Nishizawa
Association of reduction in bone mineral density with mortality in male hemodialysis patients.
Calcified tissue international 2009;84(3):180-5.
2009: Eiji Ishimura; Senji Okuno; K Kono; Y Fujino-Kato; Y Maeno; S Kagitani; N Tsuboniwa; Kyoko Nagasue; Kiyoshi Maekawa; Tomoyuki Yamakawa; Masaaki Inaba; Yoshiki Nishizawa
Glycemic control and survival of diabetic hemodialysis patients--importance of lower hemoglobin A1C levels.
Diabetes research and clinical practice 2009;83(3):320-6.
2009: Toshiki Nagasaki; Masaaki Inaba; Shinsuke Yamada; Kumi Shirakawa; Yuki Nagata; Yasuro Kumeda; Yoshikazu Hiura; Hideki Tahara; Eiji Ishimura; Yoshiki Nishizawa
Decrease of brachial-ankle pulse wave velocity in female subclinical hypothyroid patients during normalization of thyroid function: a double-blind, placebo-controlled study.
European journal of endocrinology / European Federation of Endocrine Societies 2009;160(3):409-15.
2009: Harumi Nagayama; Masaaki Inaba; Reiko Okabe; Masanori Emoto; Eiji Ishimura; Shuji Okazaki; Yoshiki Nishizawa
Glycated albumin as an improved indicator of glycemic control in hemodialysis patients with type 2 diabetes based on fasting plasma glucose and oral glucose tolerance test.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2009;63(3):236-40.
2009: Naoyoshi Onoda; Tetsuro Ishikawa; Kohei Nishio; Hideki Tahara; Masaaki Inaba; Kenichi Wakasa; Tomohiko Sumi; Takanori Yamazaki; Kazuto Shigematsu; Kosei Hirakawa
Cushing's syndrome by left adrenocortical adenoma synchronously associated with primary aldosteronism by right adrenocortical adenoma: report of a case.
Endocrine journal 2009;56(3):495-502.
2009: Daisuke Inoue; Masaaki Inaba; N Yu; Y Shima; T Ueno; Kazunari SEI; Masanori Fujita; Michihiko Ike
Evaluation of biodegradation potential of organic compounds by river water microorganisms.
Water science and technology : a journal of the International Association on Water Pollution Research 2009;59(2):317-22.
2008: Yasuro Kumeda; Masaaki Inaba; Shigeichi Shoji; Eiji Ishimura; Hiromi Inariba; Sachiko Yabe; Mikio Okamura; Yoshiki Nishizawa
Significant correlation of glycated albumin, but not glycated haemoglobin, with arterial stiffening in haemodialysis patients with type 2 diabetes.
Clinical endocrinology 2008;69(4):556-61.
2008: Shinsuke Yamada; Masaaki Inaba; Kaori Shidara; Shigeki Okada; Masanori Emoto; Eiji Ishimura; Yoshiki Nishizawa
Association of glycated albumin, but not glycated hemoglobin, with peripheral vascular calcification in hemodialysis patients with type 2 diabetes.
Life sciences 2008;83(13-14):516-9.
2008: Katsuhito Mori; Masanori Emoto; Takahiro Araki; Hisayo Yokoyama; Eiko Lee; Megumi Teramura; Hidenori Koyama; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Effects of pioglitazone on serum fetuin-A levels in patients with type 2 diabetes mellitus.
Metabolism: clinical and experimental 2008;57(9):1248-52.
2008: Shinsuke Yamada; Masaaki Inaba; Masafumi Kurajoh; Kaori Shidara; Yasuo Imanishi; Eiji Ishimura; Yoshiki Nishizawa
Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction.
Clinical endocrinology 2008;69(2):189-96.
2008: Kiyoshi Maekawa; Tetsuo Shoji; Masanori Emoto; Senji Okuno; Tomoyuki Yamakawa; Eiji Ishimura; Masaaki Inaba; Yoshiki Nishizawa
Influence of atherosclerosis on the relationship between anaemia and mortality risk in haemodialysis patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008;23(7):2329-36.
2008: M Kurajoh; Masaaki Inaba; Shinsuke Yamada; Yasuo Imanishi; Takao Tsuchida; Eiji Ishimura; Yoshiki Nishizawa
Association of increased active PTH(1-84) fraction with decreased GFR and serum Ca in predialysis CRF patients: modulation by serum 25-OH-D.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2008;19(5):709-16.
2008: Kaori Shidara; Masaaki Inaba; Senji Okuno; Shinsuke Yamada; Yasuro Kumeda; Yasuo Imanishi; Tomoyuki Yamakawa; Eiji Ishimura; Yoshiki Nishizawa
Serum levels of TRAP5b, a new bone resorption marker unaffected by renal dysfunction, as a useful marker of cortical bone loss in hemodialysis patients.
Calcified tissue international 2008;82(4):278-87.
2008: Yoshiki Nishizawa; Masaaki Inaba; Mitsukazu Ishii; Hiroyuki Yamashita; Takami Miki; Hitoshi Goto; Sinsuke Yamada; Osamu Chaki; Kentaro Kurasawa; Yoshiko Mochizuki
Reference intervals of serum tartrate-resistant acid phosphatase type 5b activity measured with a novel assay in Japanese subjects.
Journal of bone and mineral metabolism 2008;26(3):265-70.
2008: Masaaki Inaba; Tatsuji Takahashi; Yasuro Kumeda; Takayuki Kato; Fumihiko Hato; Yasutaka Yutani; Hitoshi Goto; Yoshiki Nishizawa; Seiichi Kitagawa
Increased basal phosphorylation of mitogen-activated protein kinases and reduced responsiveness to inflammatory cytokines in neutrophils from patients with rheumatoid arthritis.
Clinical and experimental rheumatology 2008;26(1):52-60.
2008: Eiji Ishimura; Senji Okuno; Hiromichi Taniwaki; Akane Kizu; Takao Tsuchida; Atsushi Shioi; Tetsuo Shoji; Tsutomu Tabata; Masaaki Inaba; Yoshiki Nishizawa
Different risk factors for vascular calcification in end-stage renal disease between diabetics and nondiabetics: the respective importance of glycemic and phosphate control.
Kidney & blood pressure research 2008;31(1):10-5.
2007: Eiji Ishimura; Senji Okuno; Tomoyuki Yamakawa; Masaaki Inaba; Yoshiki Nishizawa
Serum magnesium concentration is a significant predictor of mortality in maintenance hemodialysis patients.
Magnesium research : official organ of the International Society for the Development of Research on Magnesium 2007;20(4):237-44.
2007: Masaaki Inaba
[Bone loss in hemodialysis patients].
Nihon rinsho. Japanese journal of clinical medicine 2007;65 Suppl 9():521-5.
2007: Masaaki Inaba
[Primary osteoporosis--its diagnosis and treatment].
Nihon rinsho. Japanese journal of clinical medicine 2007;65 Suppl 9():485-9.
2007: Shinsuke Yamada; Masaaki Inaba; Yoshiki Nishizawa
[Influence on atherosclerosis of improvement of bone mineral density after medication for osteoporosis].
Nihon rinsho. Japanese journal of clinical medicine 2007;65 Suppl 9():348-51.
2007: Yasuo Imanishi; Keisuke Kobayashi; Takehisa Kawata; Masaaki Inaba; Yoshiki Nishizawa
Regulatory mechanisms of circulating fibroblast growth factor 23 in parathyroid diseases.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2007;11 Suppl 1():S32-7.
2007: Eiji Ishimura; Senji Okuno; Kayoko Kitatani; T Tsuchida; Tomoyuki Yamakawa; Atsushi Shioi; Masaaki Inaba; Yoshiki Nishizawa
Significant association between the presence of peripheral vascular calcification and lower serum magnesium in hemodialysis patients.
Clinical nephrology 2007;68(4):222-7.
2007: Takehisa Kawata; Yasuo Imanishi; Keisuke Kobayashi; Takami Miki; Andrew Arnold; Masaaki Inaba; Yoshiki Nishizawa
Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism.
Journal of the American Society of Nephrology : JASN 2007;18(10):2683-8.
2007: Toshiki Nagasaki; Masaaki Inaba; Shinsuke Yamada; Yasuro Kumeda; Yoshikazu Hiura; Yoshiki Nishizawa
Changes in brachial-ankle pulse wave velocity in subclinical hypothyroidism during normalization of thyroid function.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2007;61(8):482-7.
2007: Toshiki Nagasaki; Masaaki Inaba; Yasuro Kumeda; Misako Fujiwara-Ueda; Yoshikazu Hiura; Yoshiki Nishizawa
Significance of thyroid blood flow as a predictor of methimazole sensitivity in untreated hyperthyroid patients with Graves' disease.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2007;61(8):472-6.
2007: Megumi Teramura; Masanori Emoto; Takahiro Araki; Hisayo Yokoyama; Koka Motoyama; Kayo Shinohara; Katsuhito Mori; Hidenori Koyama; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Clinical impact of metabolic syndrome by modified NCEP-ATPIII criteria on carotid atherosclerosis in Japanese adults.
Journal of atherosclerosis and thrombosis 2007;14(4):172-8.
2007: Eiji Ishimura; Hiromichi Taniwaki; Takao Tsuchida; Naoko Obatake; Masanori Emoto; Tetsuo Shoji; Atsushi Shioi; Masaaki Inaba; Yoshiki Nishizawa
Urinary albumin excretion associated with arterial wall stiffness rather than thickness in type 2 diabetic patients.
Journal of nephrology 2007;20(2):204-11.
2007: Senji Okuno; Eiji Ishimura; Kayoko Kitatani; Yoko Fujino; Kaori Kohno; Yoshifumi Maeno; Kiyoshi Maekawa; Tomoyuki Yamakawa; Yasuo Imanishi; Masaaki Inaba; Yoshiki Nishizawa
Presence of abdominal aortic calcification is significantly associated with all-cause and cardiovascular mortality in maintenance hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2007;49(3):417-25.
2007: Masaaki Inaba; Senji Okuno; Yasuro Kumeda; Shinsuke Yamada; Yasuo Imanishi; Tsutomu Tabata; Mikio Okamura; Shigeki Okada; Tomoyuki Yamakawa; Eiji Ishimura; Yoshiki Nishizawa
Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection.
Journal of the American Society of Nephrology : JASN 2007;18(3):896-903.
2007: Toshiki Nagasaki; Masaaki Inaba; Kumi Shirakawa; Yoshikazu Hiura; Hideki Tahara; Yasuro Kumeda; Tetsuro Ishikawa; Eiji Ishimura; Yoshiki Nishizawa
Increased levels of C-reactive protein in hypothyroid patients and its correlation with arterial stiffness in the common carotid artery.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2007;61(2-3):167-72.
2007: Masaaki Inaba; Kazumasa Tanaka; Hitoshi Goto; Shinrei Sakai; Shinsuke Yamada; Hiroshi Naka; Yasuo Imanishi; Yoshiki Nishizawa
Independent association of increased trunk fat with increased arterial stiffening in postmenopausal patients with rheumatoid arthritis.
The Journal of rheumatology 2007;34(2):290-5.
2007: Kaori Shidara; Masaaki Inaba; Senji Okuno; Yasuo Imanishi; Tomoyuki Yamakawa; Eiji Ishimura; Yasuro Kumeda; Yoshiki Nishizawa
Influence of nutritional status on serum large N-truncated PTH, but not PTH(1-84) in hemodialysis patients.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2007;61(2-3):142-7.
2007: Toshiki Nagasaki; Masaaki Inaba; Yasuro Kumeda; Yoshikazu Hiura; Shinsuke Yamada; Kumi Shirakawa; Eiji Ishimura; Yoshiki Nishizawa
Central pulse wave velocity is responsible for increased brachial-ankle pulse wave velocity in subclinical hypothyroidism.
Clinical endocrinology 2007;66(2):304-8.
2007: Katsuhito Mori; Masanori Emoto; Takahiro Araki; Hisayo Yokoyama; Megumi Teramura; Eiko Lee; Koka Motoyama; Hidenori Koyama; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Association of serum fetuin-A with carotid arterial stiffness.
Clinical endocrinology 2007;66(2):246-50.
2007: Naoko Obatake; Eiji Ishimura; Takao Tsuchida; Kaname Hirowatari; Hiroshi Naka; Yasuo Imanishi; Takami Miki; Masaaki Inaba; Yoshiki Nishizawa
Annual change in bone mineral density in predialysis patients with chronic renal failure: significance of a decrease in serum 1,25-dihydroxy-vitamin D.
Journal of bone and mineral metabolism 2007;25(1):74-9.
2007: Tatsuji Takahashi; Yoshiki Nishizawa; Fumihiko Hato; Haruo Shintaku; Nobuji Maeda; Nagatoshi Fujiwara; Masaaki Inaba; Kazuo Kobayashi; Seiichi Kitagawa
Neutrophil-activating activity and platelet-activating factor synthesis in cytokine-stimulated endothelial cells: reduced activity in growth-arrested cells.
Microvascular research 2007;73(1):29-34.
2006: Masaaki Inaba; Senji Okuno; Yasuo Imanishi; Shinsuke Yamada; Atsushi Shioi; Tomoyuki Yamakawa; Eiji Ishimura; Yoshiki Nishizawa
Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2006;17(10):1506-13.
2006: Masaaki Inaba; Yoshiki Nishizawa
[Endocrine diseases presenting with hypo- or hypercalcemia].
Nihon rinsho. Japanese journal of clinical medicine 2006;Suppl 3():536-41.
2006: Shinsuke Yamada; Masaaki Inaba; Yoshiki Nishizawa
[Age-related transformation of bone metabolism].
Nihon rinsho. Japanese journal of clinical medicine 2006;64(9):1585-8.
2006: Shinsuke Yamada; Masaaki Inaba; Hitoshi Goto; Mayumi Nagata-Sakurai; Yasuro Kumeda; Yasuo Imanishi; Masanori Emoto; Eiji Ishimura; Yoshiki Nishizawa
Associations between physical activity, peripheral atherosclerosis and bone status in healthy Japanese women.
Atherosclerosis 2006;188(1):196-202.
2006: Masaaki Inaba
[Effect of aldose reductase on the abnormality of calcium metabolism in diabetic patients].
Clinical calcium 2006;16(8):1360-65.
2006: Takahiro Araki; Masanori Emoto; Megumi Teramura; Hisayo Yokoyama; Katsuhito Mori; Sawako Hatsuda; Takaaki Maeno; Kayo Shinohara; Hidenori Koyama; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Effect of adiponectin on carotid arterial stiffness in type 2 diabetic patients treated with pioglitazone and metformin.
Metabolism: clinical and experimental 2006;55(8):996-1001.
2006: Kinshi Kosaka; Naoyoshi Onoda; Tetsuro Ishikawa; Naoko Iwanaga; Seiichi Yamamasu; Hideki Tahara; Masaaki Inaba; Eiji Ishimura; Yoshinari Ogawa; Kosei Hirakawa
Laparoscopic adrenalectomy on a patient with primary aldosteronism during pregnancy.
Endocrine journal 2006;53(4):461-6.
2006: Yasuo Imanishi; Masaaki Inaba
[Secondary hyperparathyroidism].
Nihon rinsho. Japanese journal of clinical medicine 2006;Suppl 2():31-6.
2006: Yoko Fujino; Eiji Ishimura; Senji Okuno; Naoki Tsuboniwa; Kiyoshi Maekawa; Tsuyoshi Izumotani; Tomoyuki Yamakawa; Masaaki Inaba; Yoshiki Nishizawa
Annual fat mass change is a significant predictor of mortality in female hemodialysis patients.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2006;60(5):253-7.
2006: Takahiro Araki; Masanori Emoto; Hisayo Yokoyama; Takaaki Maeno; Sawako Hatsuda; Katsuhito Mori; Hidenori Koyama; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
The association of plasma adiponectin level with carotid arterial stiffness.
Metabolism: clinical and experimental 2006;55(5):587-92.
2006: Keisuke Kobayashi; Yasuo Imanishi; Hiroyuki Koshiyama; Akimitsu Miyauchi; Kenichi Wakasa; Takehisa Kawata; Hitoshi Goto; Hirotsugu Ohashi; Hajime M Koyano; Ryuichi Mochizuki; Takami Miki; Masaaki Inaba; Yoshiki Nishizawa
Expression of FGF23 is correlated with serum phosphate level in isolated fibrous dysplasia.
Life sciences 2006;78(20):2295-301.
2006: Kazumasa Tanaka; Masaaki Inaba; Hitoshi Goto; Mayumi Nagata-Sakurai; Shinrei Sakai; Shinsuke Yamada; Misako Ueda; Eiji Ishimura; Yoshiki Nishizawa
Paraarticular trabecular bone loss at the ultradistal radius and increased arterial stiffening in postmenopausal patients with rheumatoid arthritis.
The Journal of rheumatology 2006;33(4):652-8.
2006: Masaaki Inaba; Senji Okuno; Hidenori Chou; Yasuo Imanishi; Misako Ueda; Tomoyuki Yamakawa; Eiji Ishimura; Yoshiki Nishizawa
Positive correlation of serum bio-intact PTH(1-84) but not intact PTH with parathyroid gland size in hemodialysis patients.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2006;60(2):62-5.
2006: Takehisa Kawata; Yasuo Imanishi; Keisuke Kobayashi; Naoyoshi Onoda; Senji Okuno; Yoshiaki Takemoto; Takeshi Komo; Hideki Tahara; Michihito Wada; Nobuo Nagano; Eiji Ishimura; Takami Miki; Tetsuro Ishikawa; Masaaki Inaba; Yoshiki Nishizawa
Direct in vitro evidence of the suppressive effect of cinacalcet HCl on parathyroid hormone secretion in human parathyroid cells with pathologically reduced calcium-sensing receptor levels.
Journal of bone and mineral metabolism 2006;24(4):300-6.
2006: Naoshi Kubo; Naoyoshi Onoda; Tetsuro Ishikawa; Yoshinari Ogawa; Tsutomu Takashima; Yoshito Yamashita; Hideki Tahara; Masaaki Inaba; Kosei Hirakawa
Simultaneous bilateral laparoscopic adrenalectomy for adrenocorticotropic hormone-independent macronodular adrenal hyerplasia: report of a case.
Surgery today 2006;36(7):642-6.
2006: Masaaki Inaba
[Bone metabolic marker; recent progress].
Clinical calcium 2006;16(1):74-80.
2006: Keisuke Kobayashi; Yasuo Imanishi; Akimitsu Miyauchi; Naoyoshi Onoda; Takehisa Kawata; Hideki Tahara; Hitoshi Goto; Takami Miki; Eiji Ishimura; Toshitsugu Sugimoto; Tetsuro Ishikawa; Masaaki Inaba; Yoshiki Nishizawa
Regulation of plasma fibroblast growth factor 23 by calcium in primary hyperparathyroidism.
European journal of endocrinology / European Federation of Endocrine Societies 2006;154(1):93-9.
2006: Takao Tsuchida; Eiji Ishimura; Kaname Hirowatari; Naoki Matsumoto; Yasuo Imanishi; Shuichi Jono; Takami Miki; Masaaki Inaba; Yoshiki Nishizawa
Serum levels of 1-84 and 7-84 parathyroid hormone in predialysis patients with chronic renal failure measured by the intact and bio-PTH assay.
Nephron. Clinical practice 2006;102(3-4):c108-14.
2006: Hisayo Yokoyama; Masanori Emoto; Katsuhito Mori; Takahiro Araki; Megumi Teramura; Hidenori Koyama; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Plasma adiponectin level is associated with insulin-stimulated nonoxidative glucose disposal.
The Journal of clinical endocrinology and metabolism 2006;91(1):290-4.
2006: Toshiki Nagasaki; Masaaki Inaba; Yasuro Kumeda; Yoshikazu Hiura; Kumi Shirakawa; Shinsuke Yamada; Yasuko Henmi; Eiji Ishimura; Yoshiki Nishizawa
Increased pulse wave velocity in subclinical hypothyroidism.
The Journal of clinical endocrinology and metabolism 2006;91(1):154-8.
2005: Hideki Ueda; Eiji Ishimura; Takayuki Yunoki; Takao Tsuchida; Naoki Matsumoto; Syuichi Jono; Yasuo Imanishi; Masaaki Inaba; Yoshiki Nishizawa
Cimetidine-induced tubulointerstitial nephritis with both MPO-ANCA and PR3-ANCA.
Clinical and experimental nephrology 2005;9(4):332-4.
2005: Misako Ueda; Masaaki Inaba; Yasuro Kumeda; Toshiki Nagasaki; Yoshikazu Hiura; Hideki Tahara; Naoyoshi Onoda; Tetsuro Ishikawa; Yoshiki Nishizawa
The significance of thyroid blood flow at the inferior thyroid artery as a predictor for early Graves' disease relapse.
Clinical endocrinology 2005;63(6):657-62.
2005: Yoshifumi Maeno; Masaaki Inaba; Senji Okuno; Tomoyuki Yamakawa; Eiji Ishimura; Yoshiki Nishizawa
Serum concentrations of cross-linked N-telopeptides of type I collagen: new marker for bone resorption in hemodialysis patients.
Clinical chemistry 2005;51(12):2312-7.
2005: Toshiki Nagasaki; Masaaki Inaba; Yoshikazu Hiura; Hideki Tahara; Yasuro Kumeda; Kumi Shirakawa; Naoyoshi Onoda; Tetsuro Ishikawa; Eiji Ishimura; Yoshiki Nishizawa
Plasma levels of adiponectin and soluble thrombomodulin in hypothyroid patients with normal thyroid function following levothyroxine replacement therapy.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2005;59(10):571-7.
2005: Hiromichi Taniwaki; Eiji Ishimura; Tsutomu Tabata; Yoshihiro Tsujimoto; Atsushi Shioi; Tetsuo Shoji; Masaaki Inaba; Takashi Inoue; Yoshiki Nishizawa
Aortic calcification in haemodialysis patients with diabetes mellitus.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005;20(11):2472-8.
2005: Masaaki Inaba
[Primary hyperparathyroidism].
Nihon rinsho. Japanese journal of clinical medicine 2005;63 Suppl 10():325-9.
2005: Masaaki Inaba
[New assay for parathyroid hormone].
Nihon rinsho. Japanese journal of clinical medicine 2005;63 Suppl 10():306-11.
2005: Takehisa Kawata; Yasuo Imanishi; Keisuke Kobayashi; Takao Kenko; Michihito Wada; Eiji Ishimura; Takami Miki; Nobuo Nagano; Masaaki Inaba; Andrew Arnold; Yoshiki Nishizawa
Relationship between parathyroid calcium-sensing receptor expression and potency of the calcimimetic, cinacalcet, in suppressing parathyroid hormone secretion in an in vivo murine model of primary hyperparathyroidism.
European journal of endocrinology / European Federation of Endocrine Societies 2005;153(4):587-94.
2005: Takehisa Kawata; Yasuo Imanishi; Keisuke Kobayashi; Naoyoshi Onoda; Yoshiaki Takemoto; Hideki Tahara; Senji Okuno; Eiji Ishimura; Takami Miki; Tetsuro Ishikawa; Masaaki Inaba; Yoshiki Nishizawa
Direct in vitro evidence of extracellular Ca2+-induced amino-terminal truncation of human parathyroid hormone (1-84) by human parathyroid cells.
The Journal of clinical endocrinology and metabolism 2005;90(10):5774-8.
2005: Yasuo Imanishi; Takehisa Kawata; Keisuke Kobayashi; Masaaki Inaba; Yoshiki Nishizawa; Jun Shioi; Takami Miki
[Vascular calcification in advanced secondary hyperparathyroidism].
Clinical calcium 2005;15 Suppl 1():110-2; discussion 112.
2005: Kaori Shidara; Masaaki Inaba; Yasuro Kumeda; Yasuo Imanishi; Hideki Tahara; Eiji Ishimura; Yoshiki Nishizawa; Tomoyuki Yamakawa; Senji Okuno
[Significance of serum PTH (7-84) as a reliable nutritional marker in hemodialysis patients].
Clinical calcium 2005;15 Suppl 1():102-4; discussion 104-5.
2005: Takehisa Kawata; Yasuo Imanishi; Keisuke Kobayashi; Hideki Tahara; Eiji Ishimura; Masaaki Inaba; Yoshiki Nishizawa; Yoshiaki Takemoto; Naoyoshi Onoda; Senji Okuno; Tetsuro Ishikawa
[Effect of calcium on N-terminal truncation of PTH in human parathyroid cells].
Clinical calcium 2005;15 Suppl 1():98-100; discussion 100-1.
2005: Takao Tsuchida; Eiji Ishimura; Kaname Hirowatari; Naoki Matsumoto; Shuichi Jono; Takami Miki; Masaaki Inaba; Yoshiki Nishizawa
[Clinical significance of PTH (1-84) and PTH (7-84) in patients with predialysis chronic renal failure in relation to bone metabolism markers].
Clinical calcium 2005;15 Suppl 1():156-60; discussion 160.
2005: Masaaki Inaba; Yasuo Imanishi; Misako Ueda; Hidenori Cho; Hideki Tahara; Eiji Ishimura; Yoshiki Nishizawa; Tomoyuki Yamakawa; Senji Okuno
[Correlation of serum Bio-intact PTH (1-84) and parathyroid gland size in hemodialysed patients].
Clinical calcium 2005;15 Suppl 1():64-6; discussion 66-7.
2005: Toshiki Nagasaki; Masaaki Inaba
[Calcitonin, procalcitonin].
Nihon rinsho. Japanese journal of clinical medicine 2005;63 Suppl 8():295-9.
2005: Hideki Tahara; Yoshihiro Tsujimoto; Tetsuo Shoji; Masaaki Inaba; Tsutomu Tabata; Yoshiki Nishizawa
Introduction to sevelamer hydrochloride and its clinical effects.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2005;9 Suppl 1():S2-6.
2005: Misako Ueda; Masaaki Inaba; Senji Okuno; Yoshifumi Maeno; Eiji Ishimura; Tomoyuki Yamakawa; Yoshiki Nishizawa
Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
Life sciences 2005;77(10):1130-9.
2005: Takahiro Araki; Masanori Emoto; Hisayo Yokoyama; Koka Motoyama; Tomoaki Morioka; Hideki Tahara; Hidenori Koyama; Tetsuo Shoji; Yasuhisa Okuno; Masaaki Inaba; Yoshiki Nishizawa
Insulin resistance index as a predictor for pioglitazone treatment in type 2 diabetes.
Osaka city medical journal 2005;51(1):19-25.
2005: Yoko Fujino; Eiji Ishimura; Senji Okuno; Naoki Tsuboniwa; Kiyoshi Maekawa; Tsuyoshi Izumotani; Tomoyuki Yamakawa; Masaaki Inaba; Yoshiki Nishizawa
C-reactive protein is a significant predictor of decrease in fat mass in hemodialysis patients.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2005;59(5):264-8.
2005: Eiji Ishimura; Hiromichi Taniwaki; Tsutomu Tabata; Yoshihiro Tsujimoto; Shuichi Jono; Masanori Emoto; Tetsuo Shoji; Masaaki Inaba; Takashi Inoue; Yoshiki Nishizawa
Cross-sectional association of serum phosphate with carotid intima-medial thickness in hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2005;45(5):859-65.
2005: Masaaki Inaba; Senji Okuno; Yasuo Imanishi; Misako Ueda; Tomoyuki Yamakawa; Eiji Ishimura; Yoshiki Nishizawa
Significance of Bio-intact PTH(1-84) assay in hemodialysis patients.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2005;16(5):517-25.
2005: Senji Okuno; Masaaki Inaba; Kayoko Kitatani; Eiji Ishimura; Tomoyuki Yamakawa; Yoshiki Nishizawa
Serum levels of C-terminal telopeptide of type I collagen: a useful new marker of cortical bone loss in hemodialysis patients.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2005;16(5):501-9.
2005: Misako Ueda; Masaaki Inaba; Hideki Tahara; Yasuo Imanishi; Hitoshi Goto; Yoshiki Nishizawa
Hypercalcemia in a patient with primary hyperparathyroidism and acromegaly: distinct roles of growth hormone and parathyroid hormone in the development of hypercalcemia.
Internal medicine (Tokyo, Japan) 2005;44(4):307-10.
2005: Masaaki Inaba; Senji Okuno; Yasuro Kumeda; Tomoyuki Yamakawa; Eiji Ishimura; Yoshiki Nishizawa
Increased incidence of vertebral fracture in older female hemodialyzed patients with type 2 diabetes mellitus.
Calcified tissue international 2005;76(4):256-60.
2005: Toshiki Nagasaki; Masaaki Inaba; Shuichi Jono; Yoshikazu Hiura; Hideki Tahara; Kumi Shirakawa; Naoyoshi Onoda; Tetsuro Ishikawa; Eiji Ishimura; Yoshiki Nishizawa
Increased levels of serum osteoprotegerin in hypothyroid patients and its normalization with restoration of normal thyroid function.
European journal of endocrinology / European Federation of Endocrine Societies 2005;152(3):347-53.
2005: Takao Tsuchida; Eiji Ishimura; Takami Miki; Naoki Matsumoto; Hiroshi Naka; Shuichi Jono; Masaaki Inaba; Yoshiki Nishizawa
The clinical significance of serum osteocalcin and N-terminal propeptide of type I collagen in predialysis patients with chronic renal failure.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2005;16(2):172-9.
2005: Tetsuo Shoji; Hidenori Koyama; Shinya Fukumoto; Takaaki Maeno; Hisayo Yokoyama; Kayo Shinohara; Masanori Emoto; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Platelet-monocyte aggregates are independently associated with occurrence of carotid plaques in type 2 diabetic patients.
Journal of atherosclerosis and thrombosis 2005;12(6):344-52.
2005: Toshiki Nagasaki; Masaaki Inaba; Yasuro Kumeda; Misako Ueda; Yoshikazu Hiura; Hideki Tahara; Eiji Ishimura; Naoyoshi Onoda; Tetsuro Ishikawa; Yoshiki Nishizawa
Decrease of arterial stiffness at common carotid artery in hypothyroid patients by normalization of thyroid function.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2005;59(1-2):8-14.
2005: Hitoshi Goto; Masaaki Inaba
[Ibandronate as a new therapeutic agent for osteoporosis].
Clinical calcium 2005;15(1):15-7.
2005: Shinsuke Yamada; Masaaki Inaba; Hitoshi Goto; Mayumi Nagata; Misako Ueda; Kiyoshi Nakatuka; Hideki Tahara; Hisayo Yokoyama; Masanori Emoto; Tetsuo Shoji; Yoshiki Nishizawa
Significance of intima-media thickness in femoral artery in the determination of calcaneus osteo-sono index but not of lumbar spine bone mass in healthy Japanese people.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2005;16(1):64-70.
2004: Shinsuke Yamada; Masaaki Inaba
[Osteoporosis and mineral intake].
Clinical calcium 2004;14(12):96-9.
2004: Masaaki Inaba
[SERM & bone metabolism: protective effects of SERM against fracture risk and its long-term beneficial effects].
Clinical calcium 2004;14(10):27-31.
2004: Yoshiki Nishizawa; Tetsuo Shoji; Masanori Emoto; Hideki Koyama; Hideki Tahara; Shinya Fukumoto; Masaaki Inaba; Eiji Ishimura; Takami Miki
Roles of metabolic and endocrinological alterations in atherosclerosis and cardiovascular disease in renal failure: another form of metabolic syndrome.
Seminars in nephrology 2004;24(5):423-5.
2004: Eiji Ishimura; Senji Okuno; Kayoko Kitatani; Kiyoshi Maekawa; Tsuyoshi Izumotani; Tomoyuki Yamakawa; Shuichi Jono; Tetsuo Shoji; Atsushi Shioi; Masaaki Inaba; Shaul G Massry; Yoshiki Nishizawa
C-reactive protein is a significant predictor of vascular calcification of both aorta and hand arteries.
Seminars in nephrology 2004;24(5):408-12.
2004: Hisayo Yokoyama; Masanori Emoto; Shigehiko Fujiwara; Koka Motoyama; Tomoaki Morioka; Hidenori Koyama; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Short-term aerobic exercise improves arterial stiffness in type 2 diabetes.
Diabetes research and clinical practice 2004;65(2):85-93.
2004: Toshiki Nagasaki; Masaaki Inaba
[Growth hormone / prolactin].
Nihon rinsho. Japanese journal of clinical medicine 2004;62 Suppl 6():173-7.
2004: Reiko Okabe; Masaaki Inaba; Shinrei Sakai; Eiji Ishimura; Atushi Moriguchi; Tetsuo Shoji; Yoshiki Nishizawa
Increased arterial stiffening and thickening in the paretic lower limb in patients with hemiparesis.
Clinical science (London, England : 1979) 2004;106(6):613-8.
2004: Yasuo Imanishi; Masaaki Inaba; Kiyoshi Nakatsuka; Kyoko Nagasue; Senji Okuno; Asami Yoshihara; Masakazu Miura; Akimitsu Miyauchi; Keisuke Kobayashi; Takami Miki; Tetsuo Shoji; Eiji Ishimura; Yoshiki Nishizawa
FGF-23 in patients with end-stage renal disease on hemodialysis.
Kidney international 2004;65(5):1943-6.
2004: Shinsuke Yamada; Masaaki Inaba; Yoshiki Nishizawa
[Metabolic bone disease and bone quality].
Clinical calcium 2004;14(4):573-9.
2004: Eiko Lee; Hideki Tahara; Tetsuo Shoji; Mayumi Nagata; Misako Ueda; Shinsuke Yamada; Hitoshi Goto; Masaaki Inaba; Yoshiki Nishizawa
[Case Report No.138:One case of advanced renal hyperparathyroidim complicated with acute renal failure].
Clinical calcium 2004;14(3):462-5.
2004: Hisayo Yokoyama; Masanori Emoto; Shigehiko Fujiwara; Koka Motoyama; Tomoaki Morioka; Miyoko Komatsu; Hideki Tahara; Hidenori Koyama; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment are useful indexes of insulin resistance in type 2 diabetic patients with wide range of fasting plasma glucose.
The Journal of clinical endocrinology and metabolism 2004;89(3):1481-4.
2004: Misako Ueda; Masaaki Inaba
[Serum PINP(N-terminal propeptide of type I procollagen)].
Nihon rinsho. Japanese journal of clinical medicine 2004;62 Suppl 2():373-7.
2004: Masaaki Inaba; Misako Ueda
[Carboxyl-terminal propeptide of type I collagen(PICP)].
Nihon rinsho. Japanese journal of clinical medicine 2004;62 Suppl 2():345-8.
2004: Toshiki Nagasaki; Masaaki Inaba; Yasuko Henmi; Yasuro Kumeda; Misako Ueda; Hideki Tahara; Eiji Ishimura; Naoyoshi Onoda; Tetsuro Ishikawa; Yoshiki Nishizawa
Change in von Willebrand factor and carotid intima-media thickness in hypothyroid patients with normal thyroid function after levothyroxine replacement therapy.
European journal of endocrinology / European Federation of Endocrine Societies 2004;150(2):125-31.
2004: Masaaki Inaba; Kiyoshi Nakatsuka; Yasuo Imanishi; Masakazu Watanabe; Yuji Mamiya; Eiji Ishimura; Yoshiki Nishizawa
Technical and clinical characterization of the Bio-PTH (1-84) immunochemiluminometric assay and comparison with a second-generation assay for parathyroid hormone.
Clinical chemistry 2004;50(2):385-90.
2004: Takami Miki; Kiyoshi Nakatsuka; Hiroshi Naka; Hideki Masaki; Yasuo Imanishi; Masako Ito; Masaaki Inaba; Hirotoshi Morii; Yoshiki Nishizawa
Effect and safety of intermittent weekly administration of human parathyroid hormone 1-34 in patients with primary osteoporosis evaluated by histomorphometry and microstructural analysis of iliac trabecular bone before and after 1 year of treatment.
Journal of bone and mineral metabolism 2004;22(6):569-76.
2004: Masaaki Inaba
Secondary osteoporosis: thyrotoxicosis, rheumatoid arthritis, and diabetes mellitus.
Journal of bone and mineral metabolism 2004;22(4):287-92.
2004: Naoyoshi Onoda; Kana Ogisawa; Tetsuro Ishikawa; Chiemi Takenaka; Hideki Tahara; Masaaki Inaba; Tsutomu Takashima; Kosei Hirakawa
Telomerase activation and expression of its catalytic subunits in benign and malignant tumors of the parathyroid.
Surgery today 2004;34(5):389-93.
2004: Tsutomu Takashima; Naoyoshi Onoda; Tetsuro Ishikawa; Tsuyoshi Koyama; Masaaki Inaba; Yoshiki Nishizawa; Tatsuya Nakatani; Kenichi Wakasa; Kosei Hirakawa
Tumor-forming idiopathic retroperitoneal fibrosis: report of a case.
Surgery today 2004;34(4):374-8.
2004: Kiyoshi Nakatsuka; Takami Miki; Hiroshi Naka; Masaaki Inaba; Yoshiki Nishizawa
Long-term effect of intermittent cyclical etidronate on microarchitecture and quality of trabecular bone in an elderly woman with severe osteoporosis.
Journal of bone and mineral metabolism 2004;22(2):153-8.
2004: Reiko Okabe; Masaaki Inaba; Kiyoshi Nakatsuka; Takami Miki; Hiroshi Naka; Atushi Moriguchi; Yoshiki Nishizawa
Significance of serum CrossLaps as a predictor of changes in bone mineral density during estrogen replacement therapy; comparison with serum carboxyterminal telopeptide of type I collagen and urinary deoxypyridinoline.
Journal of bone and mineral metabolism 2004;22(2):127-31.
2004: Tetsuo Shoji; Kayo Shinohara; Eiji Kimoto; Masanori Emoto; Hideki Tahara; Hidenori Koyama; Masaaki Inaba; Shinya Fukumoto; Eiji Ishimura; Takami Miki; Tsutomu Tabata; Yoshiki Nishizawa
Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19(1):179-84.
2003: Senji Okuno; Eiji Ishimura; Kayoko Kitatani; Hidenori Chou; Kyoko Nagasue; Kiyoshi Maekawa; Tsuyoshi Izumotani; Tomoyuki Yamakawa; Yasuo Imanishi; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Relationship between parathyroid gland size and responsiveness to maxacalcitol therapy in patients with secondary hyperparathyroidism.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2003;18(12):2613-21.
2003: Toshiki Nagasaki; Masaaki Inaba; Yasuko Henmi; Yasuro Kumeda; Misako Ueda; Hideki Tahara; Shigeru Sugiguchi; Shigehiko Fujiwara; Masanori Emoto; Eiji Ishimura; Naoyoshi Onoda; Tetsuro Ishikawa; Yoshiki Nishizawa
Decrease in carotid intima-media thickness in hypothyroid patients after normalization of thyroid function.
Clinical endocrinology 2003;59(5):607-12.
2003: Mayumi Nagata-Sakurai; Masaaki Inaba; Hitoshi Goto; Yasuro Kumeda; Yutaka Furumitsu; Kentaro Inui; Hidenori Koyama; Masanori Emoto; Eiji Ishimura; Tetsuo Shoji; Yoshiki Nishizawa
Inflammation and bone resorption as independent factors of accelerated arterial wall thickening in patients with rheumatoid arthritis.
Arthritis and rheumatism 2003;48(11):3061-7.
2003: Kayoko Goya; Tetsuhiro Kitamura; Masaaki Inaba; Michio Otsuki; Hiroyasu Yamamoto; Shogo Kurebayashi; Satoru Sumitani; Hiroshi Saito; Haruhiko Kouhara; Soji Kasayama; Ichiro Kawase
Risk factors for asymptomatic atherosclerosis in Japanese type 2 diabetic patients without diabetic microvascular complications.
Metabolism: clinical and experimental 2003;52(10):1302-6.
2003: Akane Kizu; Hidenori Koyama; Shinji Tanaka; Takaaki Maeno; Miyoko Komatsu; Shinya Fukumoto; Masanori Emoto; Tetsuo Shoji; Masaaki Inaba; Atsushi Shioi; Takami Miki; Yoshiki Nishizawa
Arterial wall stiffness is associated with peripheral circulation in patients with type 2 diabetes.
Atherosclerosis 2003;170(1):87-91.
2003: Hidenori Koyama; Takaaki Maeno; Shinya Fukumoto; Tetsuo Shoji; Takahisa Yamane; Hisayo Yokoyama; Masanori Emoto; Tetsuo Shoji; Hideki Tahara; Masaaki Inaba; Masayuki Hino; Atsushi Shioi; Takami Miki; Yoshiki Nishizawa
Platelet P-selectin expression is associated with atherosclerotic wall thickness in carotid artery in humans.
Circulation 2003;108(5):524-9.
2003: Masaaki Inaba; Mayumi Nagata; Hitoshi Goto; Yasuro Kumeda; Keisuke Kobayashi; Kiyoshi Nakatsuka; Takami Miki; Shinsuke Yamada; Eiji Ishimura; Yoshiki Nishizawa
Preferential reductions of paraarticular trabecular bone component in ultradistal radius and of calcaneus ultrasonography in early-stage rheumatoid arthritis.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2003;14(8):683-7.
2003: Koka Motoyama; Masanori Emoto; Hideki Tahara; Miyoko Komatsu; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Association of muscle glycogen synthase polymorphism with insulin resistance in type 2 diabetic patients.
Metabolism: clinical and experimental 2003;52(7):895-9.
2003: Naoki Matsumoto; Eiji Ishimura; Hidenori Koyama; Shinji Tanaka; Yasuo Imanishi; Atsushi Shioi; Masaaki Inaba; Yoshiki Nishizawa
Blocking of alpha 5 integrin stimulates production of TGF-beta and PAI-1 by human mesangial cells.
Biochemical and biophysical research communications 2003;305(4):815-9.
2003: Hideki Ueda; Eiji Ishimura; Tetsuo Shoji; Masanori Emoto; Tomoaki Morioka; Naoki Matsumoto; Shinya Fukumoto; Takami Miki; Masaaki Inaba; Yoshiki Nishizawa
Factors affecting progression of renal failure in patients with type 2 diabetes.
Diabetes care 2003;26(5):1530-4.
2003: Yoshiki Nishizawa; Tetsuo Shoji; Ryusuke Kakiya; Yoshihiro Tsujimoto; Tsutomu Tabata; Eiji Ishimura; Tatsuya Nakatani; Takami Miki; Masaaki Inaba
Non-high-density lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal disease.
Kidney international. Supplement 2003;(84):S117-20.
2003: Kyoko Nagasue; Masaaki Inaba; Senji Okuno; Kayoko Kitatani; Yasuo Imanishi; Eiji Ishimura; Takami Miki; Masao Kim; Yoshiki Nishizawa
Serum N-terminal midfragment vs. intact osteocalcin immunoradiometric assay as markers for bone turnover and bone loss in hemodialysis patients.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2003;57(2):98-104.
2003: Yoko Fujino; Masaaki Inaba; Kiyoshi Nakatsuka; Yasuro Kumeda; Yasuo Imanishi; Hideki Tahara; Takeo Goto; Yuichi Inoue; Tatsuya Nakatani; Tetsuro Ishikawa; Eiji Ishimura; Yoshiki Nishizawa
Primary hyperparathyroidism with multiple osteosclerotic lesions of the calvarium.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2003;18(3):410-2.
2003: Eiji Ishimura; Senji Okuno; Taro Marukawa; Yoshikazu Katoh; Toshiyuki Hiranaka; Tomoyuki Yamakawa; Hirotoshi Morii; Masao Kim; Naoki Matsumoto; Tetsuo Shoji; Masaaki Inaba; Tatsuya Nakatani; Yoshiki Nishizawa
Body fat mass in hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2003;41(3 Suppl 1):S137-41.
2003: Yoshiki Nishizawa; Tetsuo Shoji; Kiyoshi Maekawa; Kyoko Nagasue; Senji Okuno; Masao Kim; Masanori Emoto; Eiji Ishimura; Tatsuya Nakatani; Takami Miki; Masaaki Inaba
Intima-media thickness of carotid artery predicts cardiovascular mortality in hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2003;41(3 Suppl 1):S76-9.
2003: Eiji Kimoto; Tetsuo Shoji; Kayo Shinohara; Masaaki Inaba; Yasuhisa Okuno; Takami Miki; Hidenori Koyama; Masanori Emoto; Yoshiki Nishizawa
Preferential stiffening of central over peripheral arteries in type 2 diabetes.
Diabetes 2003;52(2):448-52.
2003: Shigehiko Fujiwara; Masanori Emoto; Miyoko Komatsu; Koka Motoyama; Tomoaki Morioka; Hidenori Koyama; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Arterial wall thickness is associated with insulin resistance in type 2 diabetic patients.
Journal of atherosclerosis and thrombosis 2003;10(4):246-52.
2003: Hiromichi Taniwaki; Eiji Ishimura; Takahiko Kawagishi; Naoki Matsumoto; Masayuki Hosoi; Masanori Emoto; Tetsuo Shoji; Shigeichi Shoji; Tatsuya Nakatani; Masaaki Inaba; Yoshiki Nishizawa
Intrarenal hemodynamic changes after captopril test in patients with type 2 diabetes: a duplex Doppler sonography study.
Diabetes care 2003;26(1):132-7.
2003: Yasuo Imanishi; Kiyoshi Nakatsuka; Tetsuo Nakayama; Terue Okamura; Keisuke Kobayashi; Keiko Nakayama; Eiji Ishimura; Masaaki Inaba; Yoshiki Nishizawa
False-positive magnetic resonance imaging skeletal survey in a patient with sporadic hypophosphatemic osteomalacia.
Journal of bone and mineral metabolism 2003;21(1):57-9.
2002: Yoko Fujino; Masaaki Inaba; Yasuo Imanishi; Mayumi Nagata; Hitoshi Goto; Yasuro Kumeda; Tatsuya Nakatani; Eiji Ishimura; Yoshiki Nishizawa
A case of SIADH induced by mizoribin administration.
Nephron 2002;92(4):938-40.
2002: Yasuro Kumeda; Masaaki Inaba; Yoshiki Nishizawa
[Diabetes mellitus and osteoporosis].
Nihon rinsho. Japanese journal of clinical medicine 2002;60 Suppl 10():393-403.
2002: Eiji Ishimura; Senji Okuno; Kayoko Kitatani; Masao Kim; Tetsuo Shoji; T Nakatani; Masaaki Inaba; Yoshiki Nishizawa
Different risk factors for peripheral vascular calcification between diabetic and non-diabetic haemodialysis patients--importance of glycaemic control.
Diabetologia 2002;45(10):1446-8.
2002: Misako Ueda; Masaaki Inaba; Senji Okuno; Kyoko Nagasue; Kayoko Kitatani; Eiji Ishimura; Motokazu Shimizu; Takami Miki; Masao Kim; Yoshiki Nishizawa
Clinical usefulness of the serum N-terminal propeptide of type I collagen as a marker of bone formation in hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2002;40(4):802-9.
2002: Kana Ogisawa; Naoyoshi Onoda; Tetsuro Ishikawa; Chiemi Takenaka; Masaaki Inaba; Yoshinari Ogawa; Kosei Hirakawa-Y S Chung
Establishment and characterization of OCUT-1, an undifferentiated thyroid cancer cell line expressing high level of telomerase.
Journal of surgical oncology 2002;80(4):197-203.
2002: Masaaki Inaba; Yasuko Henmi; Yasuro Kumeda; Misako Ueda; Mayumi Nagata; Masanori Emoto; Tetsuro Ishikawa; Eiji Ishimura; Yoshiki Nishizawa
Increased stiffness in common carotid artery in hyperthyroid Graves' disease patients.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2002;56(5):241-6.
2002: Naoyoshi Onoda; Tetsuro Ishikawa; Nobuya Yamada; Terue Okamura; Hideki Tahara; Masaaki Inaba; Tsutomu Takashima; Yoji Sakate; Kosei Hirakawa-Y S Chung
Radioisotope-navigated video-assisted thoracoscopic operation for ectopic mediastinal parathyroid.
Surgery 2002;132(1):17-9.
2002: Isao Kawasaki; Hideki Tahara; Masanori Emoto; Tetsuo Shoji; Atsushi Shioji; Yasuhisa Okuno; Masaaki Inaba; Yoshiki Nishizawa
Impact of Prol2Ala variant in the peroxisome proliferator-activated receptor (PPAR) gamma2 on obesity and insulin resistance in Japanese Type 2 diabetic and healthy subjects.
Osaka city medical journal 2002;48(1):23-8.
2002: Kouka Motoyama; Masaaki Inaba; Masanori Emoto; Hirotoshi Morii; Yoshiki Nishizawa
Sarcoidosis initially manifesting as symptomatic hypercalcemia with the absence of organic involvement.
Internal medicine (Tokyo, Japan) 2002;41(6):449-52.
2002: Yasuro Kumeda; Masaaki Inaba; Hitoshi Goto; Mayumi Nagata; Yasuko Henmi; Yutaka Furumitsu; Eiji Ishimura; Kentaro Inui; Yasutaka Yutani; Takami Miki; Tetsuo Shoji; Yoshiki Nishizawa
Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis.
Arthritis and rheumatism 2002;46(6):1489-97.
2002: Masaaki Inaba; Kyoko Nagasue; Senji Okuno; Misako Ueda; Yasuro Kumeda; Yasuo Imanishi; Tetsuo Shoji; Eiji Ishimura; Tomohiro Ohta; Tatsuya Nakatani; Masao Kim; Yoshiki Nishizawa
Impaired secretion of parathyroid hormone, but not refractoriness of osteoblast, is a major mechanism of low bone turnover in hemodialyzed patients with diabetes mellitus.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2002;39(6):1261-9.
2002: Masaaki Inaba
[Regulation of adhesion molecules by calcium].
Clinical calcium 2002;12(5):583-6.
2002: Hideki Ueda; Eiji Isimura; Senji Okuno; Kiyoshi Maekawa; Tsuyoshi Izumotani; Masao Kim; Naoki Matsumoto; Shinya Fukumoto; Yasuo Imanishi; Masanori Emoto; Tetsuo Shoji; Hideki Wanibuchi; Masaaki Inaba; Yoshiki Nishizawa
[Sibling cases of nephritis resembling membranoproliferative glomerulonephritis].
Nihon Jinzo Gakkai shi 2002;44(4):420-6.
2002: Takaaki Maeno; Hidenori Koyama; Hideki Tahara; Miyoko Komatsu; Masanori Emoto; Tetsuo Shoji; Masaaki Inaba; Takami Miki; Yasuhisa Okuno; Yoshiki Nishizawa
The 807T allele in alpha2 integrin is protective against atherosclerotic arterial wall thickening and the occurrence of plaque in patients with type 2 diabetes.
Diabetes 2002;51(5):1523-8.
2002: Naoki Matsumoto; Eiji Ishimura; Hiromichi Taniwaki; Masanori Emoto; Tetsuo Shoji; Takahiko Kawagishi; Masaaki Inaba; Yoshiki Nishizawa
Smoking and proteinuria impair vasodilatory response of intrarenal arteries to nitroglycerine in patients with type 2 diabetes mellitus.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2002;17(4):608-13.
2002: Yasuro Kumeda; Masaaki Inaba
[Diabetic osteoporosis].
Nihon rinsho. Japanese journal of clinical medicine 2002;60 Suppl 3():459-67.
2002: Masaaki Inaba
[Alendronate in the treatment of osteoporosis].
Nihon rinsho. Japanese journal of clinical medicine 2002;60 Suppl 3():373-80.
2002: Eiji Kimoto; Tetsuo Shoji; Masanori Emoto; Takami Miki; Tsutomu Tabata; Yasuhisa Okuno; Eiji Ishimura; Masaaki Inaba; Yoshiki Nishizawa
Effect of diabetes on uremic dyslipidemia.
Journal of atherosclerosis and thrombosis 2002;9(6):305-13.
2002: Tetsuro Ishikawa; Naoyoshi Onoda; Yoshinari Ogawa; Tsutomu Takashima; Nobuo Matsunaga; Shinya Michigami; Terue Okamura; Hideki Tahara; Masaaki Inaba; Tatsuya Nakatani; Kosei Hirakawa
Thoracoscopic excision for ectopic mediastinal parathyroid tumor.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2002;56 Suppl 1():34s-36s.
2001: Senji Okuno; Eiji Ishimura; Masao Kim; Tsuyoshi Izumotani; T Otoshi; Kiyoshi Maekawa; Tomoyuki Yamakawa; Hirotoshi Morii; Masaaki Inaba; Yoshiki Nishizawa
Changes in body fat mass in male hemodialysis patients: a comparison between diabetics and nondiabetics.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2001;38(4 Suppl 1):S208-11.
2001: Eiji Ishimura; Tetsuo Shoji; Masanori Emoto; K Motoyama; K Shinohara; Naoki Matsumoto; Hiromichi Taniwaki; Masaaki Inaba; Yoshiki Nishizawa
Renal insufficiency accelerates atherosclerosis in patients with type 2 diabetes mellitus.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2001;38(4 Suppl 1):S186-90.
2001: Masaaki Inaba; Senji Okuno; Kyoko Nagasue; T Otoshi; Y Kurioka; Kiyoshi Maekawa; Yasuro Kumeda; Yasuo Imanishi; Eiji Ishimura; T Ohta; Hirotoshi Morii; Masao Kim; Yoshiki Nishizawa
Impaired secretion of parathyroid hormone is coherent to diabetic hemodialyzed patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2001;38(4 Suppl 1):S139-42.
2001: Tetsuo Shoji; Eiji Ishimura; Masaaki Inaba; Tsutomu Tabata; Yoshiki Nishizawa
Atherogenic lipoproteins in end-stage renal disease.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2001;38(4 Suppl 1):S30-3.
2001: Yoshiki Nishizawa; Tetsuo Shoji; Eiji Ishimura; Masaaki Inaba; Hirotoshi Morii
Paradox of risk factors for cardiovascular mortality in uremia: is a higher cholesterol level better for atherosclerosis in uremia?
American journal of kidney diseases : the official journal of the National Kidney Foundation 2001;38(4 Suppl 1):S4-7.
2001: Tsuyoshi Izumotani; Eiji Ishimura; T Yamamoto; T Otoshi; Senji Okuno; Masaaki Inaba; Masao Kim; Yoshiki Nishizawa
Correlation between peritoneal mesothelial cell cytology and peritoneal histopathology with respect to prognosis in patients on continuous ambulatory peritoneal dialysis.
Nephron 2001;89(1):43-9.
2001: Hiromichi Taniwaki; Eiji Ishimura; Naoki Matsumoto; Masanori Emoto; Masaaki Inaba; Yoshiki Nishizawa
Relations between ACE gene and ecNOS gene polymorphisms and resistive index in type 2 diabetic patients with nephropathy.
Diabetes care 2001;24(9):1653-60.
2001: Eiji Ishimura; Senji Okuno; Masao Kim; T Yamamoto; Tsuyoshi Izumotani; T Otoshi; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Increasing body fat mass in the first year of hemodialysis.
Journal of the American Society of Nephrology : JASN 2001;12(9):1921-6.
2001: Hiromichi Taniwaki; Tetsuo Shoji; Masanori Emoto; Takahiko Kawagishi; Eiji Ishimura; Masaaki Inaba; Yasuhisa Okuno; Yoshiki Nishizawa
Femoral artery wall thickness and stiffness in evaluation of peripheral vascular disease in type 2 diabetes mellitus.
Atherosclerosis 2001;158(1):207-14.
2001: Reiko Okabe; Kiyoshi Nakatsuka; Masaaki Inaba; Takami Miki; Hiroshi Naka; Hideki Masaki; Atushi Moriguchi; Yoshiki Nishizawa
Clinical evaluation of the Elecsys beta-CrossLaps serum assay, a new assay for degradation products of type I collagen C-tlopeptides.
Clinical chemistry 2001;47(8):1410-4.
2001: M Waki; Masaaki Inaba; Yoshikazu Hiura; Toshiki Nagasaki; Yasuo Imanishi; Eiji Ishimura; Shuzo Otani; Yoshiki Nishizawa
Modulation by cAMP of 1alpha,25-dihydroxyvitamin D3 sensitivity of murine erythroleukemia cells.
Archives of biochemistry and biophysics 2001;391(2):265-70.
2001: Masaaki Inaba
[Significance of biochemical markers for bone metabolism in the treatment of parathyroid and thyroid disorders].
Clinical calcium 2001;11(7):910-4.
2001: Tetsuo Shoji; Masanori Emoto; Takahiko Kawagishi; Eiji Kimoto; A Yamada; Tsutomu Tabata; Eiji Ishimura; Masaaki Inaba; Yasuhisa Okuno; Yoshiki Nishizawa
Atherogenic lipoprotein changes in diabetic nephropathy.
Atherosclerosis 2001;156(2):425-33.
2001: Masanori Emoto; H Kanda; Tetsuo Shoji; Takahiko Kawagishi; Miyoko Komatsu; Katsuhito Mori; Hideki Tahara; Eiji Ishimura; Masaaki Inaba; Yasuhisa Okuno; Yoshiki Nishizawa
Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes.
Diabetes care 2001;24(3):533-8.
2001: Y Kurioka; Masaaki Inaba; Takahiko Kawagishi; Masanori Emoto; Yasuro Kumeda; Y Inoue; Hirotoshi Morii; Yoshiki Nishizawa
Increased retinal blood flow in patients with Graves' disease: influence of thyroid function and ophthalmopathy.
European journal of endocrinology / European Federation of Endocrine Societies 2001;144(2):99-107.
2001: Masaaki Inaba; Yoshiki Nishizawa
[Perspective of alendronate from the standpoint of internist].
Clinical calcium 2001;11(1):57-60.
2000: Yasuro Kumeda; Masaaki Inaba; Hideki Tahara; Y Kurioka; Tetsuro Ishikawa; Hirotoshi Morii; Yoshiki Nishizawa
Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.
The Journal of clinical endocrinology and metabolism 2000;85(11):4157-61.
2000: Hideki Tahara; Yasuo Imanishi; T Yamada; Yoshihiro Tsujimoto; Tsutomu Tabata; Takashi Inoue; Masaaki Inaba; Hirotoshi Morii; Yoshiki Nishizawa
Rare somatic inactivation of the multiple endocrine neoplasia type 1 gene in secondary hyperparathyroidism of uremia.
The Journal of clinical endocrinology and metabolism 2000;85(11):4113-7.
2000: Naoki Matsumoto; Eiji Ishimura; Hiromichi Taniwaki; Masanori Emoto; Tetsuo Shoji; Takahiko Kawagishi; Masaaki Inaba; Yoshiki Nishizawa
Diabetes mellitus worsens intrarenal hemodynamic abnormalities in nondialyzed patients with chronic renal failure.
Nephron 2000;86(1):44-51.
2000: Hiromichi Taniwaki; Eiji Ishimura; Masanori Emoto; Takahiko Kawagishi; Naoki Matsumoto; Tetsuo Shoji; T Okamura; Masaaki Inaba; Yoshiki Nishizawa
Relationship between urinary albumin excretion and glomerular filtration rate in normotensive, nonproteinuric patients with type 2 diabetes mellitus.
Nephron 2000;86(1):36-43.
2000: Tetsuro Ishikawa; Masaaki Inaba; Yukio Nishiguchi; R Ishibashi; Kana Ogisawa; Kiyotaka Yukimoto; Yoshinari Ogawa; Naoyoshi Onoda; Kosei Hirakawa; Y S Chung
Laparoscopic adrenalectomy for benign adrenal tumors.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2000;54 Suppl 1():183s-186s.
2000: Masaaki Inaba; Tetsuro Ishikawa; Yasuo Imanishi; Eiji Ishimura; Kiyoshi Nakatsuka; Hirotoshi Morii; Yoshiki Nishizawa
Pathophysiology and diagnosis of primary hyperparathyroidism--strategy for asymptomatic primary hyperparathyroidism.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2000;54 Suppl 1():7s-11s.
2000: Yutaka Furumitsu; Kazuhiko Yukioka; Masao Yukioka; Takahiro Ochi; Yoshihiro Morishima; I Matsui-Yuasa; S Otani; Masaaki Inaba; Yoshiki Nishizawa; Hirotoshi Morii
Interleukin-1beta induces elevation of spermidine/spermine N1-acetyltransferase activity and an increase in the amount of putrescine in synovial adherent cells from patients with rheumatoid arthritis.
The Journal of rheumatology 2000;27(6):1352-7.
2000: Masaaki Inaba; Hirotoshi Morii; T Katsumata; Hitoshi Goto; Eiji Ishimura; Takahiko Kawagishi; M Kamao; T Okano; Yoshiki Nishizawa
Hyperparathyroidism is augmented by ovariectomy in Nagase analbuminemic rats.
The Journal of nutrition 2000;130(6):1543-7.
2000: Yasuo Imanishi; Masaaki Inaba
[Autoimmune hypoparathyroidism].
Ryōikibetsu shōkōgun shirīzu 2000;(31):108-11.
2000: Yutaka Furumitsu; Masaaki Inaba; Kazuhiko Yukioka; Masao Yukioka; Yasuro Kumeda; Y Azuma; T Ohta; Takahiro Ochi; Yoshiki Nishizawa; Hirotoshi Morii
Levels of serum and synovial fluid pyridinium crosslinks in patients with rheumatoid arthritis.
The Journal of rheumatology 2000;27(1):64-70.
1999: Masaaki Inaba; Hirotoshi Morii
[Calcitonin (CT)].
Nihon rinsho. Japanese journal of clinical medicine 1999;57 Suppl():118-20.
1999: Takahiko Kawagishi; M Matsuyoshi; Masanori Emoto; Hiromichi Taniwaki; H Kanda; Yasuhisa Okuno; Masaaki Inaba; Eiji Ishimura; Yoshiki Nishizawa; Hirotoshi Morii
Impaired endothelium-dependent vascular responses of retinal and intrarenal arteries in patients with type 2 diabetes.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(10):2509-16.
1999: Yasuo Imanishi; Masaaki Inaba; H Seki; H Koyama; Yoshiki Nishizawa; Hirotoshi Morii; Shuzo Otani
Increased biological potency of hexafluorinated analogs of 1,25-dihydroxyvitamin D3 on bovine parathyroid cells.
The Journal of steroid biochemistry and molecular biology 1999;70(4-6):243-8.
1999: Masaaki Inaba
[Autoimmune polyglandular syndrome].
Nihon rinsho. Japanese journal of clinical medicine 1999;57(8):1888-93.
1999: Toshiki Nagasaki; Eiji Ishimura; Hidenori Koyama; Atsushi Shioi; Shuichi Jono; Masaaki Inaba; Tadayoshi Hasuma; M Yokoyama; Yoshiki Nishizawa; Hirotoshi Morii; Shuzo Otani
Alphav integrin regulates TNF-alpha-induced nitric oxide synthesis in rat mesangial cells--possible role of osteopontin.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1999;14(8):1861-6.
1999: Masaaki Inaba; M Terada; Yoshiki Nishizawa; Atsushi Shioi; Eiji Ishimura; S Otani; Hirotoshi Morii
Protective effect of an aldose reductase inhibitor against bone loss in galactose-fed rats: possible involvement of the polyol pathway in bone metabolism.
Metabolism: clinical and experimental 1999;48(7):904-9.
1999: R Okabe; Masaaki Inaba; M Hosoi; E Ishimura; Yasuro Kumeda; Yoshiki Nishizawa; Hirotoshi Morii
Remission of insulin autoimmune syndrome in a patient with Grave's disease by treatment with methimazole.
Internal medicine (Tokyo, Japan) 1999;38(6):482-5.
1999: Yoshikazu Hiura; Masaaki Inaba; Yoshiki Nishizawa; Shuzo Otani; Hirotoshi Morii
Synergistic enhancement by 12-O-tetradecanoylphorbol-13-acetate and dibutyryl cAMP of 1alpha,25-dihydroxyvitamin D3 action in human promyelocytic leukemic HL-60 cells.
Endocrine journal 1999;46(2):317-24.
1999: Eiji Ishimura; Yoshiki Nishizawa; Masaaki Inaba; N Matsumoto; Masanori Emoto; Takahiko Kawagishi; S Shoji; Senji Okuno; M Kim; Takami Miki; Hirotoshi Morii
Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure.
Kidney international 1999;55(3):1019-27.
1999: Masaaki Inaba; Yoshiki Nishizawa; K Mita; Yasuro Kumeda; Masanori Emoto; Takahiko Kawagishi; Eiji Ishimura; Kiyoshi Nakatsuka; Atsushi Shioi; Hirotoshi Morii
Poor glycemic control impairs the response of biochemical parameters of bone formation and resorption to exogenous 1,25-dihydroxyvitamin D3 in patients with type 2 diabetes.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1999;9(6):525-31.
1998: H Shimada; T Miki; I Kyogoku; Takahiko Kawagishi; Masaaki Inaba; Y Okuno; Yoshiki Nishizawa; Hirotoshi Morii
[Effects of the aldose reductase inhibitor on diabetic polyneuropathy--the efficacy of F wave measurement].
Nō to shinkei = Brain and nerve 1998;50(9):817-20.
1998: E Tsuda-Futami; Atsushi Shioi; Shuichi Jono; Masaaki Inaba; Yoshiki Nishizawa; Hirotoshi Morii
Lymphoblastoid interferon-alpha downregulates parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptor expression in human osteoblastic cells (Saos-2).
Bone 1998;23(3):205-11.
1998: T Takahashi; Yoshiki Nishizawa; Masanori Emoto; Takahiko Kawagishi; Naoki Matsumoto; Eiji Ishimura; Masaaki Inaba; Yasuhisa Okuno; H Shimada; Hirotoshi Morii
Sympathetic function test of vasoconstrictor changes in foot arteries in diabetic patients.
Diabetes care 1998;21(9):1495-501.
1998: Masanori Emoto; Yoshiki Nishizawa; Takahiko Kawagishi; Kiyoshi Maekawa; Yoshikazu Hiura; H Kanda; K Izumotani; Tetsuo Shoji; Eiji Ishimura; Masaaki Inaba; Yasuhisa Okuno; Hirotoshi Morii
Stiffness indexes beta of the common carotid and femoral arteries are associated with insulin resistance in NIDDM.
Diabetes care 1998;21(7):1178-82.
1998: Yasuro Kumeda; Masaaki Inaba; Yoshiki Nishizawa
[Secondary osteoporosis and its treatment--diabetes mellitus].
Nihon rinsho. Japanese journal of clinical medicine 1998;56(6):1579-86.
1998: Eiji Ishimura; Yoshiki Nishizawa; S Okuno; N Matsumoto; Masanori Emoto; Masaaki Inaba; Takahiko Kawagishi; C W Kim; H Morii
Diabetes mellitus increases the severity of anemia in non-dialyzed patients with renal failure.
Journal of nephrology 1998;11(2):83-6.
1998: M Terada; Masaaki Inaba; Yoshihisa Yano; Tadayoshi Hasuma; Yoshiki Nishizawa; Hirotoshi Morii; Shuzo Otani
Growth-inhibitory effect of a high glucose concentration on osteoblast-like cells.
Bone 1998;22(1):17-23.
1997: Takahiko Kawagishi; Yoshiki Nishizawa; Hiromichi Taniwaki; S Tanaka; Yasuhisa Okuno; Masaaki Inaba; Eiji Ishimura; Masanori Emoto; Hirotoshi Morii
Relationship between gastric emptying and an alpha-glucosidase inhibitor effect on postprandial hyperglycemia in NIDDM patients.
Diabetes care 1997;20(10):1529-32.
1997: Masanori Emoto; Yoshiki Nishizawa; Kiyoshi Maekawa; Takahiko Kawagishi; K Kogawa; Yoshikazu Hiura; Katsuhito Mori; S Tanaka; Eiji Ishimura; Masaaki Inaba; Yasuhisa Okuno; Hirotoshi Morii
Insulin resistance in non-obese, non-insulin-dependent diabetic patients with diabetic nephropathy.
Metabolism: clinical and experimental 1997;46(9):1013-8.
1997: Toshiki Nagasaki; M Hino; Masaaki Inaba; Yoshiki Nishizawa; Hirotoshi Morii; Shuzo Otani
Inhibition by 1alpha,25-dihydroxyvitamin D3 of activin A-induced differentiation of murine erythroleukemic F5-5 cells.
Archives of biochemistry and biophysics 1997;343(2):181-7.
1997: Kiyoshi Nakatsuka; Masaaki Inaba; H Aratani; K Iba; T Sato; T Koike; Takami Miki; Yoshiki Nishizawa; Hirotoshi Morii
[Effects of long-term administration of alfacalcidol on bone mass and bone metabolism in patients with primary osteoporosis--comparison with calcium preparations].
Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 1997;34(7):569-76.
1997: Eiji Ishimura; Yoshiki Nishizawa; Takahiko Kawagishi; Yasuhisa Okuno; K Kogawa; Shinya Fukumoto; Kiyoshi Maekawa; Masayuki Hosoi; Masaaki Inaba; Masanori Emoto; Hirotoshi Morii
Intrarenal hemodynamic abnormalities in diabetic nephropathy measured by duplex Doppler sonography.
Kidney international 1997;51(6):1920-7.
1997: Takahiko Kawagishi; Yoshiki Nishizawa; Masanori Emoto; Kiyoshi Maekawa; Yasuhisa Okuno; Hiromichi Taniwaki; Masaaki Inaba; Eiji Ishimura; Hirotoshi Morii
Gastric myoelectrical activity in patients with diabetes. Role of glucose control and autonomic nerve function.
Diabetes care 1997;20(5):848-54.
1997: Toshiki Nagasaki; Eiji Ishimura; Atsushi Shioi; Shuichi Jono; Masaaki Inaba; Yoshiki Nishizawa; Hirotoshi Morii; Shuzo Otani
Osteopontin gene expression and protein synthesis in cultured rat mesangial cells.
Biochemical and biophysical research communications 1997;233(1):81-5.
1997: Masaaki Inaba; Yoshiki Nishizawa; Atsushi Shioi; Hirotoshi Morii
Importance of sustained high glucose condition in the development of diabetic osteopenia: possible involvement of the polyol pathway.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1997;7 Suppl 3():S209-12.
1997: Hirotoshi Morii; Atsushi Shioi; Masaaki Inaba; Hitoshi Goto; Takahiko Kawagishi; Kiyoshi Nakatsuka; Yoshiki Nishizawa; H Takahashi; H Sone; T Katsumata
Significance of albumin in the pathogenesis of osteoporosis: bone changes in genetically analbuminemic rats and rats fed a low albumin diet.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1997;7 Suppl 3():S30-5.
1997: Masaaki Inaba; Kazuhiko Yukioka; Yutaka Furumitsu; Mitsuyuki Murano; Hitoshi Goto; Yoshiki Nishizawa; Hirotoshi Morii
Positive correlation between levels of IL-1 or IL-2 and 1,25(OH)2D/25-OH-D ratio in synovial fluid of patients with rheumatoid arthritis.
Life sciences 1997;61(10):977-85.
1996: Masayuki Hosoi; Yoshiki Nishizawa; K Kogawa; Takahiko Kawagishi; T Konishi; Kiyoshi Maekawa; Masanori Emoto; Shinya Fukumoto; Atsushi Shioi; Tetsuo Shoji; Masaaki Inaba; Yasuhisa Okuno; Hirotoshi Morii
Angiotensin-converting enzyme gene polymorphism is associated with carotid arterial wall thickness in non-insulin-dependent diabetic patients.
Circulation 1996;94(4):704-7.
1996: Y Imanishi; H Koyama; Masaaki Inaba; S Okuno; Yoshiki Nishizawa; Hirotoshi Morii; Shuzo Otani
Phosphorus intake regulates intestinal function and polyamine metabolism in uremia.
Kidney international 1996;49(2):499-505.
1996: Eiji Ishimura; Terue Okamura; H Masaki; Yoshikazu Hiura; Takahiko Kawagishi; Masaaki Inaba; Yoshiki Nishizawa; Hironobu Ochi; Hirotoshi Morii
Amyloid goiter: radiological study in a case presenting hypothyroidism.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1996;28(1):27-31.
1996: Masayuki Hino; Masaaki Inaba; H Goto; Yoshiki Nishizawa; N Tatsumi; T Nishino; Hirotoshi Morii
Hepatocyte growth factor levels in bone marrow plasma of patients with leukaemia and its gene expression in leukaemic blast cells.
British journal of cancer 1996;73(1):119-23.
1995: Masaaki Inaba; M Terada; H Koyama; O Yoshida; Eiji Ishimura; Takahiko Kawagishi; Y Okuno; Yoshiki Nishizawa; Shuzo Otani; Hirotoshi Morii
Influence of high glucose on 1,25-dihydroxyvitamin D3-induced effect on human osteoblast-like MG-63 cells.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1995;10(7):1050-6.
1995: Masaaki Inaba; Hirotoshi Morii
[Polyglandular autoimmune syndrome].
Nihon rinsho. Japanese journal of clinical medicine 1995;53(4):974-8.
1995: Hirotoshi Morii; Yoshiki Nishizawa; M Smogorzewski; Masaaki Inaba; S G Massry
New actions of parathyroid hormone. Introduction.
Mineral and electrolyte metabolism 1995;21(1-3):7-8.
1995: S Shoji; Yoshiki Nishizawa; Tsutomu Tabata; Masanori Emoto; A Morita; H Goto; E Ishimaura; T Inoue; Masaaki Inaba; Takami Miki
Influence of serum phosphate on the efficacy of oral 1,25-dihydroxyvitamin D3 pulse therapy.
Mineral and electrolyte metabolism 1995;21(1-3):223-8.
1995: S Okuno; Masaaki Inaba; Yoshiki Nishizawa; Hirotoshi Morii
Biological activities of 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3 on human promyelocytic leukemic HL-60 cells: effects of fetal bovine serum and of incubation time.
Mineral and electrolyte metabolism 1995;21(1-3):211-6.
1995: E Ishimura; Yoshiki Nishizawa; H Koyama; S Shoji; Masaaki Inaba; Hirotoshi Morii
Impaired vitamin D metabolism and response in spontaneously diabetic GK rats.
Mineral and electrolyte metabolism 1995;21(1-3):205-10.
1995: O Yoshida; Masaaki Inaba; M Terada; Atsushi Shioi; Yoshiki Nishizawa; Shuzo Otani; Hirotoshi Morii
Impaired response of human osteosarcoma (MG-63) cells to human parathyroid hormone induced by sustained exposure to high glucose.
Mineral and electrolyte metabolism 1995;21(1-3):201-4.
1995: Y Imanishi; Masaaki Inaba; Yoshiki Nishizawa; Hirotoshi Morii; Shuzo Otani
Involvement of polyamines in the proliferation of bovine parathyroid cells.
Mineral and electrolyte metabolism 1995;21(1-3):197-200.
1995: Takahiko Kawagishi; Yoshiki Nishizawa; Masanori Emoto; K Kawasaki; S Shoji; Masaaki Inaba; Takami Miki; A Morita; Tsutomu Tabata; T Inoue
Growth of parathyroid gland in uremic patients on maintenance hemodialysis.
Mineral and electrolyte metabolism 1995;21(1-3):104-8.
1994: H Koyama; Masaaki Inaba; Yoshiki Nishizawa; Eiji Ishimura; Y Imanishi; M Hini; T Furuyama; H Takagi; Hirotoshi Morii
Potentiated 1,25(OH)2D3-induced 24-hydroxylase gene expression in uremic rat intestine.
The American journal of physiology 1994;267(6 Pt 2):F926-30.
1994: K Yukioka; Masaaki Inaba; Y Furumitsu; M Yukioka; T Nishino; H Goto; Yoshiki Nishizawa; Hirotoshi Morii
Levels of hepatocyte growth factor in synovial fluid and serum of patients with rheumatoid arthritis and release of hepatocyte growth factor by rheumatoid synovial fluid cells.
The Journal of rheumatology 1994;21(12):2184-9.
1994: H Koyama; Masaaki Inaba; Yoshiki Nishizawa; S Ohno; Hirotoshi Morii
Protein kinase C is involved in 24-hydroxylase gene expression induced by 1,25(OH)2D3 in rat intestinal epithelial cells.
Journal of cellular biochemistry 1994;55(2):230-40.
1994: H Koyama; Yoshiki Nishizawa; Masaaki Inaba; Masayuki Hino; J M Prahl; H F DeLuca; Hirotoshi Morii
Impaired homologous upregulation of vitamin D receptor in rats with chronic renal failure.
The American journal of physiology 1994;266(5 Pt 2):F706-12.
1994: K Kogawa; Masaaki Inaba; Y Okuno; Takami Miki; Yoshiki Nishizawa; Hirotoshi Morii
[A case of temporary severe disequilibrium hypercalcemia].
Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 1994;31(2):142-6.
1994: Yoshihiro Morishima; Masaaki Inaba; Yoshiki Nishizawa; Hirotoshi Morii; Tadayoshi Hasuma; Isao Matsui-Yuasa; Shuzo Otani
The involvement of polyamines in the activation of vitamin D receptor from porcine intestinal mucosa.
European journal of biochemistry / FEBS 1994;219(1-2):349-56.
1994: Eiji Ishimura; S Shoji; H Koyama; Masaaki Inaba; Yoshiki Nishizawa; Hirotoshi Morii
Presence of gene expression of vitamin D receptor and 24-hydroxylase in OK cells.
FEBS letters 1994;337(1):48-51.
1994: K Kogawa; Masaaki Inaba; Y Okuno; Yoshiki Nishizawa; Hirotoshi Morii
A case of temporary severe disequilibrium hypercalcemia.
Mineral and electrolyte metabolism 1994;20(3):163-8.
1993: S Okuno; Masaaki Inaba; Yoshiki Nishizawa; Hirotoshi Morii
[Isolated ACTH deficiency associated with Hashimoto disease].
Nihon rinsho. Japanese journal of clinical medicine 1993;51(10):2721-5.
1993: Eiji Ishimura; Takami Miki; H Koyama; K Harada; Kiyoshi Nakatsuka; Masaaki Inaba; Yoshiki Nishizawa; Hirotoshi Morii
Effect of aminohydroxypropylidene diphosphonate on the bone metabolism of patients with parathyroid adenoma.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1993;25(9):493-7.
1993: Masaaki Inaba; H Koyama; Masayuki Hino; S Okuno; M Terada; Yoshiki Nishizawa; T Nishino; Hirotoshi Morii
Regulation of release of hepatocyte growth factor from human promyelocytic leukemia cells, HL-60, by 1,25-dihydroxyvitamin D3, 12-O-tetradecanoylphorbol 13-acetate, and dibutyryl cyclic adenosine monophosphate.
Blood 1993;82(1):53-9.
1993: Masaaki Inaba; S Okuno; Yoshiki Nishizawa; Y Imanishi; T Katsumata; I Sugata; Hirotoshi Morii
Effect of substituting fluorine for hydrogen at C-26 and C-27 on the side chain of 1,25-dihydroxyvitamin D3.
Biochemical pharmacology 1993;45(11):2331-6.
1993: Masaaki Inaba; S Okuno; H Koyama; Eiji Ishimura; Yoshiki Nishizawa; Hirotoshi Morii
Effect of uremic serum on 1,25-dihydroxyvitamin D3-induced differentiation of human promyelocytic leukemia cell, HL-60.
Nephron 1993;63(2):152-8.
1992: Masaaki Inaba; Hirotoshi Morii
[Vitamin D3].
Nihon rinsho. Japanese journal of clinical medicine 1992;50(12):2956-61.
1992: H Koyama; J M Prahl; A Uhland; M Nanjo; Masaaki Inaba; Yoshiki Nishizawa; Hirotoshi Morii; Y Nishii; H F DeLuca
A new, highly sensitive assay for 1,25-dihydroxyvitamin D not requiring high-performance liquid chromatography: application of monoclonal antibody against vitamin D receptor to radioreceptor assay.
Analytical biochemistry 1992;205(2):213-9.
1992: Masaaki Inaba; Yoshiki Nishizawa; K Song; H Tanishita; S Okuno; Takami Miki; Hirotoshi Morii
Partial protection of 1 alpha-hydroxyvitamin D3 against the development of diabetes induced by multiple low-dose streptozotocin injection in CD-1 mice.
Metabolism: clinical and experimental 1992;41(6):631-5.
1992: Masaaki Inaba; S Okuno; H Koyama; Yoshiki Nishizawa; Hirotoshi Morii
Dibutyryl cAMP enhances the effect of 1,25-dihydroxyvitamin D3 on a human promyelocytic leukemia cell, HL-60, at both the receptor and the postreceptor steps.
Archives of biochemistry and biophysics 1992;293(1):181-6.
1992: Masaaki Inaba; S Okuno; Y Imanishi; Yoshiki Nishizawa; Hirotoshi Morii
Magnesium deficiency enhances secretion of parathyroid hormone in normal and 5/6-nephrectomized uremic rats.
Journal of endocrinological investigation 1992;15(9 Suppl 6):135-42.
1991: Masaaki Inaba; S Okuno; H Koyama; Yoshiki Nishizawa; Hirotoshi Morii
Effects of uremic serum on 1,25-dihydroxyvitamin D3-induced differentiation of a human promyelocytic leukemia cell line, HL-60.
Journal of nutritional science and vitaminology 1991;37 Suppl():S93-103.
1991: H Koyama; H Tahara; Tetsuo Shoji; Yoshiki Nishizawa; Masaaki Inaba; Shuzo Otani; M Yanagisawa; Y Ishiguro; N Takanashi; Hirotoshi Morii
Uremic serum contains humoral factor(s) larger than fifty kilodaltons which suppresses endothelin production in cultured endothelial cells.
Contributions to nephrology 1991;90():111-5.
1991: Masaaki Inaba; Hirotoshi Morii; H F DeLuca
Significance of proteolytic activity in 1,25-(OH)2D3-induced differentiation of HL-60 cells.
Contributions to nephrology 1991;91():102-8.
1990: H Mizutani; T Furubayashi; A Kuriu; H Take; Yoshiaki Tomiyama; H Yoshida; Y Nakamura; Masaaki Inaba; Yoshiyuki Kurata; T Yonezawa
Analyses of thrombocytopenia in idiopathic thrombocytopenic purpura-prone mice by platelet transfer experiments between (NZW x BXSB)F1 and normal mice.
Blood 1990;75(9):1809-12.
1990: Masaaki Inaba; Yoshiki Nishizawa; Hirotoshi Morii
[Tissue distribution and physiologic role of calcitonin and CGRP].
Nihon rinsho. Japanese journal of clinical medicine 1990;48(5):1011-5.
1989: Masaaki Inaba; S Okuno; A Inoue; Yoshiki Nishizawa; Hirotoshi Morii; H F DeLuca
DNA binding property of vitamin D3 receptors associated with 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3.
Archives of biochemistry and biophysics 1989;268(1):35-9.
1988: Yoshiki Nishizawa; Y Okui; Masaaki Inaba; S Okuno; K Yukioka; Takami Miki; Y Watanabe; Hirotoshi Morii
Calcium/calmodulin-mediated action of calcitonin on lipid metabolism in rats.
The Journal of clinical investigation 1988;82(4):1165-72.
1988: K Yukioka; Shuzo Otani; Isao Matsui-Yuasa; H Goto; S Morisawa; S Okuno; Masaaki Inaba; Yoshiki Nishizawa; Hirotoshi Morii
Biological activity of 26,26,26,27,27,27-hexafluorinated analogs of vitamin D3 in inhibiting interleukin-2 production by peripheral blood mononuclear cells stimulated by phytohemagglutinin.
Archives of biochemistry and biophysics 1988;260(1):45-50.
1987: Masaaki Inaba; S Okuno; Yoshiki Nishizawa; K Yukioka; Shuzo Otani; Isao Matsui-Yuasa; S Morisawa; H F DeLuca; Hirotoshi Morii
Biological activity of fluorinated vitamin D analogs at C-26 and C-27 on human promyelocytic leukemia cells, HL-60.
Archives of biochemistry and biophysics 1987;258(2):421-5.
1986: Masaaki Inaba; Shuzo Otani; Isao Matsui-Yuasa; K Yukioka; Yoshiki Nishizawa; E Ishimura; S Morisada; M Yukioka; S Morisawa; Hirotoshi Morii
Polyamines in 1 alpha, 25-dihydroxycholecalciferol-induced differentiation of human promyelocytic leukemia cells, HL-60.
Endocrinology 1986;118(5):1849-55.